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Abstract
Survival analysis is a long-lasting and popular research area and has numerous ap-
plications in all fields such as social science, engineering, economics, industry, and
public health. Interval-censored data are a special type of survival data, in which the
survival time of interest is never exactly observed but is known to fall within some
observed interval. Interval-censored data arise commonly in real-life studies, in which
subjects are examined at periodical or irregular follow-up visits. In this dissertation,
we develop efficient statistical approaches for regression analysis of bivariate interval-
censored data, in which the two survival times of interest are correlated and both
have an interval-censored data structure.
Chapter 1 first describes the structure of interval-censored data in detail, and
four real-life data sets are presented for illustrations. A literature review is provided
regarding the existing semiparametric regression models and methods on interval-
censored data. The last section of this chapter provides some important background
knowledge to be used in later chapter of this dissertation, such as Kendall’s τ and
Dirichlet process mixture model.
Chapter 2 proposes a novel and fast EM algorithm for regression analysis of bi-
variate current status data based on the Gamma-frailty proportional hazards (PH)
model. Monotone splines are adopted to approximate the unknown conditional base-
line cumulative functions. A three-stage data augmentation is proposed and leads to
a complete data likelihood in a simple form. An EM algorithm is further derived uti-
lizing this complete likelihood. The resulting algorithm is easy to implement, robust
to initialization, and enjoys quick convergence. The proposed method has excellent
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performance in estimating the regression parameters, the baseline survival function-
s, and the statistical association between the both failure times through simulation
studies. The method is also robust to the misspecifications of frailty distribution.
Moreover, the method is much faster than existing approaches in the literature. Our
method is illustrated by a real-life application about the prevalence of antibodies to
hepatitis B and HIV among Irish prisoners.
In Chapter 3, I revisit the topic on bivariate current status data but from a
Bayesian perspective. Two Bayesian methods are proposed: one for Gamma-frailty
PH model and one for frailty PH model with unknown frailty distribution. A Dirich-
let process Gamma mixture model is proposed for modeling the unknown frailty
distribution. Efficient Gibbs samplers are proposed for these two models. Simula-
tion results suggest that both of the two proposed methods work well in the cases
of correctly specified and misspecified frailty distributions. The method based on
the Gamma-frailty PH model is preferred because of its simpler model structure and
robust performance in addition to providing Kendall’s τ in closed form.
Chapter 4 investigates Bayesian regression analysis of bivariate interval-censored
data. First, an efficient method is proposed based on the Gamma-frailty PH model,
and simulation studies show that the proposed method works well when the model is
correctly specified. It is also observed that the method leads to biased estimates when
the two failure times are independent or weakly correlated. To handle both dependent
and independent cases, a mixture of gamma and point mass at one is proposed for
the frailty distribution. An efficient Gibbs sampler is proposed and is shown to have
good performance in both cases through simulation studies. A read-life data set from
an AIDs clinical trial is analyzed for illustration.
v
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Survival data involve the time to some event of interest such as the time to onset (or
relapse) of a disease. A special feature of survival data is the possibility of censoring
(Cox and Oakes 1984) because the exact failure time of the event is not available to
observe directly. For example, the time to the instant status change of some type of
tumors is not obtainable due to the loss to follow-up or non-occurrence of the tumor
at the end of the study. Alternatively, some incomplete observation of failure time is
available such as the examination time, the dropout time, or the ending time of the
study. Such the observation time is referred to as censoring time. In some studies,
there may be more than one censoring times for each subject due to the design of the
study.
Various of censoring types can be found in the censored data: left-censoring, right-
censoring and interval-censoring, which are defined by the relationship between the
failure time and the censoring time. A left- or right-censored observation arises when
the failure time is smaller or greater than the censoring time. An interval-censored
observation appears when the failure time event is known to have occurred between
two examination times with changed status. General interval-censored data contain
all these three types of censored observations, and such data naturally result from
studies with periodical examinations. A special type of interval-censored data is
called current status data, in which all the failure times are either left censored or
right censored. Current status data appear commonly in cross-sectional studies, in
which there is only one examination time for all subjects. Current status data are
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also referred to as case 1 interval-censored data, and general interval-censored data
are also referred to as case 2 interval-censored data in the literature.
The remainder of this chapter is organized as follows: Sections 1.1 and 1.2 demon-
strate different types of interval-censored data with four real examples. Section 1.3
reviews existing approaches for the regression analysis of the multivariate interval-
censored data. Section 1.4 discusses the Gamma-frailty proportional hazards (PH)
model, which is the fundamental model throughout the dissertation. Section 1.5
reviews the most common method to estimate the association among correlated sur-
vival data. Section 1.6 provides background knowledge about Dirichlet process and
Dirichlet process mixture models. Such knowledge will help readers understand the
proposed nonparametric approach allowing a random distribution for frailty in Chap-
ter 3.
1.1 Current status data
Current status data commonly arise in many epidemiological, social, and medical s-
tudies. For example, in tumorigenicity studies conducted by the National Toxicology
Program, rats are exposed to different test agents in an effort to assess their toxicity.
Researchers then examine the animals’ organs for tumors at the time of their death.
Consequently, the tumor onset time for a particular animal is never known exactly,
but rather is known relative to the animal’s time of death; i.e., the tumor onset time is
either before or after the time of death. Hoel and Walberg (1972) described a tumori-
genicity experiment which was designed to investigate lung tumors on 144 mice. The
experiment consisted of two treatments: conventional environment(CE) and germ-
free environment(GE). The researchers were interested in discovering whether there
is any significant difference of tumor occurrence time under two environments. In the
experiment, these mice were examined for lung tumors only at the time when they
died during the study or were sacrificed at the end of the study. Consequently, the
2
Table 1.1 Death times and lung tumor status for 144 male RFM mice
Group Tumor status Death times
CE 1 381, 477, 485, 515, 539, 563, 565, 582, 603, 616
624, 650, 651, 656, 659, 672, 679, 698, 702, 709
723, 731, 775, 779, 795, 811, 839
0 45, 198, 215, 217, 257, 262, 266, 371, 431, 447
454, 459, 475, 479, 484, 500, 502, 503, 505, 508
516, 531, 541, 553, 556, 570, 572, 575, 577, 585
588, 594, 600, 601, 608, 614, 616, 632, 632, 638
642, 642, 642, 644, 644, 647, 647, 653, 659, 660
662, 663, 667, 667, 673, 673, 677, 689, 693, 718
720, 721, 728, 760, 762, 773, 777, 815, 886
GE 1 546, 609, 692, 692, 710, 752, 773, 781, 782, 789
808, 810, 814, 842, 846, 851, 871, 873, 876, 888
888, 890, 894, 896, 911, 913, 914, 914, 916, 921
921, 926, 936, 945, 1008
0 412, 524, 647, 648, 695, 785, 814, 817, 851, 880
913, 942, 986
tumor onset times were never known exactly but were known to be smaller or larger
than their death or sacrifice times according to their tumor status. From Table 1.1,
the tumor status 1 means the lung tumor was found at the death and the onset time
is left-censored by the death time and 0 indicates the onset time is right-censored.
Therefore, this tumor data can be regarded as case 1 interval-censored data or current
status data.
Bivariate current status data occur in the situation when two correlated failure
times are recorded but each subject is observed only once. The failure times of interest
are either left or right-censored. Allright et al. (2000) explored a real life data from
a survey carried out among prisoners in the Republic of Ireland in 1999. The survey
was conducted to determine the prevalence of antibodies to hepatitis B and HIV. The
experimental designer examined many possible risk factors such as: current sentence
status, time spent in prison in the past 10 years, history of smoking heroin, the
history of injecting the drug, the age when first injecting the drug, history of sexual
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transmitted disease etc. The responses were collected in the form of questionnaires.
The infection status of each of the participants, for both diseases, were determined
according to an oral fluid test. From the data description, the occurrence time of the
infection for each prisoner was not observed directly but is either smaller or greater
than the age of the prisoner at the time of testing. Hence, the data set can be
considered as bivariate current status data.
1.2 Case 2 interval-censored data
Case 2 interval-censored data often arise when periodic scheduled follow-ups for
patients are implemented in some clinical trials or studies such as monitoring the
progress of chronic diseases like AIDS or cancer. A typical example of such data was
reported in Finkelstein and Wolfe (1985) reproduced from a breast cancer study. It
contained 94 patients subject to early breast cancer which were assigned to one of
two treatment groups, radiotherapy alone or radiation therapy together with adju-
vant chemotherapy. In the study, the patients were monitored to detect the cosmetic
appearance like breast retraction during the clinic visits every 4 to 6 months. The
actual examination times differ from patient to patient since some of them missed
their visits. The goal of the study is to investigate the difference between the two
treatments for their effects on the rate of change of deterioration of the cosmetic state.
From the description of the study, we notice that the exact event time for the instant
change of the cosmetic appearance was not observable but was within some interval
between visits. Therefore, The failure times for the appearance of breast retraction
of each patient were interval-censored, which are presented in Table 1.2.
In Chapter 4 we focus on bivariate interval-censored data. The data set we use to
evaluate our approaches is the AIDS data from the ACTG 181 study (Goggins and
Finkelstein , 2000; Finkelstein, et al., 2002). In this study, patients were required to
provide their urine samples every 4 weeks and blood samples every 12 weeks. The
4
Table 1.2 Interval times (in months) of cosmetic deterioration (retraction) for
early breast cancer patients
Radiotherapy alone Radiation with adjuvant chemotherapy
(45,] (25,37] (37,] (4,11] (8,12] (0,5] (30,34] (16,20]
(17,25] (6,10] (46,] (0,5] (13,] (0,22] (5,8] (13,]
(33,] (15,] (0,7] (26,40] (30,36] (18,25] (24,31] (12,20]
(18,] (46,] (19,26] (46,] (10,17] (17,24] (18,24] (17,27]
(46,] (24,] (11,15] (11,18] (17,27] (11,] (8,21] (17,26]
(46,] (27,34] (36,] (37,] (35,] (17,23] (33,40] (4,9]
(22,] (7,16] (36,44] (5,12] (16,60] (33,] (24,30] (31,]
(38,] (34,] (17,] (46,] (11,] (15,22] (35,39] (16,24]
(19,35] (46,] (5,12] (9,14] (13,39] (15,19] (23,] (11,17]
(36,48] (17,25] (36,] (46,] (13,] (19,32] (4,8] (22,]
(37,44] (37,] (24,] (0,8] (44,48] (11,13] (34,] (34,]
(40,] (33,] (22,32] (11,20] (14,17] (10,35]
samples were tested for the presence of the cytomeglovirus (CMV) virus referred to
as shedding of virus. Since the existence of the CMV shedding can not be observed
directly from any symptoms, the actual onset time is then not available but is related
to the testing time according to the test result. For example, some patients returned
with changed CMV shedding status which produced the interval-censored failure time.
Some patients did not have the changed CMV shedding until the last visit, which
resulted in right-censored failure time. Some already started the CMV shedding from
the entrance to the study, which indicated the failure time was left-censored. This
type of data is called general interval-censored data or case 2 interval-censored data.
1.3 Existing approaches
The primary goals of analyzing multivariate data are usually centered around the
estimation of the survival functions, assessing the significance of covariate effects,
and estimating the correlation between failure times. Typically, the analysis of cor-
related survival data is approached from either one of two perspective; i.e., from
either the marginal likelihood or frailty model approach. Existing work which does
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not fall within these two categories includes Wang et al. (2008)) based on copula
models and Kim (2014) based on multistate models, among others. The marginal
likelihood approach (Wei, et al., 1989; Guo and Lin, 1994; Cai and Prentice, 1995),
which ignores the correlation between each of the failure times, has been a popular
method of analyzing multivariate survival data. Various regression models have been
proposed and investigated for studying current status and interval-censored data us-
ing the marginal likelihood approach. For example, Goggins and Finkelstein (2000)
and Kim et al. (2002) studied correlated interval-censored data using the marginal
proportional hazards (PH) model. Chen, et al. (2007) and Tong et al. (2008) in-
vestigated the marginal proportional odds model and the marginal additive hazards
model, respectively. Even though the likelihood approach can provide robust infer-
ence in general, it does not account for the correlation that naturally exists between
the multiple failure times.
In order to acknowledge the underlying correlation structure, the frailty model ap-
proach is commonly used to jointly model multivariate survival data; i.e., one or more
frailty terms are introduced in order to describe the dependence structure between the
multiple responses. For example, Vaida and Xu (2000) used the the PH model with
normal frailty to analyze the clustered survival data. Huang and Wolf (2002) treated
censoring as dependent in the clustered data for the frailty model. Dunson and Dinse
(2002) proposed a probit model with normal frailty for bivariate current status data
with informative censoring. Komarek and Lesaffre (2007) proposed a frailty acceler-
ated failure time model for correlated interval-censored data. Zuma (2007) explored
the Gamma-frailty Weibull model for multivariate interval-censored data. Chen et al.
(2009) studied multivariate current status data under the PH model with a normal
frailty. Lin and Wang (2011) proposed a Bayesian proportional odds models with a
shared gamma frailty for bivariate or clustered current status data. Callegaro and
Lacobeli (2012) proposed a Cox model with log-skewed-normal frailties for clustered
6
right-censored data. For a more in depth review of frailty modeling techniques in
survival analysis please see Hougaard (2000), Ibrahim et al. (2008), and Wienke
(2012).
1.4 The Gamma-frailty proportional hazards (PH) model
The PH model was first introduced by Cox in 1972 (Cox,1972). It defines the hazard
function λ(t;x) as
λ(t;x) = λ0(t) exp(x′β), (1.1)
where the λ0(t) is an arbitrary unknown baseline hazard function and β is the vector
of regression parameters corresponding with covariate x. with the specification of
hazard function (1.1), the survival function can be expressed as
S(t;x) = exp(−Λ0(t) exp(x′β)), (1.2)
where Λ0(t) =
∫ t
0 λ0(s)ds is the cumulative baseline function.
Clayton (1978) first proposed to use gamma frailty in modeling correlated fail-
ure times, and since then the Gamma-frailty model has been used extensively. The
Gamma-frailty PH model, as a special Gamma-frailty model, has been widely used
for studying correlated survival data. It incorporates the random effect with a mul-
tiplicative gamma distributed latent variable on the baseline hazard:
λ(t;x, η) = λ0(t) exp(x′β)η. (1.3)
The frailty term η describes the heterogeneity among the subjects in the study. A
Gamma distribution G(ν, ν) is commonly used with mean 1 and variance ν−1. The
common shape and rate parameters in the gamma distribution guarantees mean 1
and avoids the non-identifiability issue between η and unspecified λ0.
In literature, we can find a substantially large number of papers which contribute
to developing methods for multivariate survival data under Gamma-frailty PH mod-
el. Guo and Rodriguez (1992) provided an EM algorithm for clustered data under
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Gamma-frailty PH model. For the purposes of analyzing multivariate right-censored
data the Gamma-frailty PH model has become also quite popular; e.g., see Klein
(1992), Andersen et al. (1997), Rondeau et al. (2003), Cui and Sun (2004), and Yin
and Ibrahim (2005) among many others. In contrast, the Gamma-frailty PH is less
frequently adopted for studying multivariate current status or interval-censored data,
due to the complex structure of this data. Chang et al. (2007) and Wen and Chen
(2011) studied the Gamma-frailty PH model from a theoretical and computational
perspectives but for clustered current status data. Hens et al. (2009) proposed a
correlated Gamma-frailty PH model for bivariate current status data. Considering
the popularity of the frailty PH model, further efforts to develop flexible techniques
of analyzing multivariate current status and interval-censored data under this model
are obviously needed. In this dissertation, we propose Bayesian and frequentist ap-
proaches to analyze the bivariate current status data and general interval-censored
data under Gamma-frailty PH model.
1.5 Estimation of the association of bivariate interval-censored data
As mentioned above, one of primary goals for the bivariate interval-censored data
analysis is to quantify the association of the two failure times. The copula model
is one of the commonly used models for bivariate data to estimate the association.
Shih and Louis (1995) and Hsu and Prentice (1996) applied a copula model to derive
the dependence for bivariate right-censored data. Sun et al. (2006) proposed an
estimation of the association between two correlated interval-censored failure times
followed by a copula model.
Copula model defines the joint survival function as
S(s, t) = Cαc{S1(s), S2(t)},
where s and t are two survival times with respect to the two events, Cαc is a genuine
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survival function mapping the unit square [0, 1]2 to [0, 1], and αc is a global association
of parameter. S1 and S2 are the marginal survival functions of two interested failure
times, respectively. The flexibility of choosing different genuine functions is one of the
attractive features to when applying the copula model in survival analysis. For exam-
ple, Archimedean copula is one of the many bivsariate survival model families which
represents the joint distribution as Cαc{S1(s), S2(t)} = φαc
[
φ−1αc {S1(s)}, φ−1αc {S2(t)}
]
.
If specifying φ as the Laplace transformation of Gamma distribution, we obtain
Cαc{S1(s), S2(t)} =
[
{S1(s)}1−αc + {S2(t)}1−αc − 1
]1/(1−αc)
, αc > 1, (1.4)
which is commonly referred to as Clayton copula (Clayton, 1978). In the following
chapters, one may notice the joint survival function derived from Gamma-frailty PH
model is a special case of Clayton copula.
A worth noting from the different copula models is that the association parameter
αc is difficult to directly interpret the correlation due to different genuine function.
Commonly, Kendall’s τ , the rank correlation coefficient, is derived to measure the
correlation. It is defined as
τ = E[sign{(Ti1 − Tj1)(Ti2 − Tj2)}],
where (Ti1, Ti2) and (Tj1, Tj2) are two independent and identically distributed copies
of (T1, T2) and sign(·) is the usual sign function; i.e., this function takes values 1, 0,
and -1 when the argument is positive, zero, and negative, respectively. Consequently,
one can re-express τ as
τ = Pr{(Ti1 − Tj1)(Ti2 − Tj2) > 0} − Pr{(Ti1 − Tj1)(Ti2 − Tj2) < 0}.






Under Clayton copula (1.4), Kendall’s τ is explicitly represented via τ = αc − 1
αc + 1
.
Under Gamma-frailty PH model, it can be represented as τ = 11 + 2ν .
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1.6 Dirichlet process mixture model
In Chapter 3, we propose a Dirichlet process Gamma mixture distribution to allow
random distribution of the frailty in the frailty PH model. Dirichlet process (D-
P) is currently one of the most popular Bayesian nonparametric models which was
first introduced in (Ferguson, 1973) for general Bayesian statistical modeling in non-
parametric problems. DP, denoted by DP(αH0), is defined by two parameters a
positive concentration parameter α and a probability base measure H0. Suppose a
random distribution H is distributed according to DP(αH0) over a parameter space
Θ: H ∼ DP(αH0). Then for any finite measurable partition {A1, A2, ..., Aq} of Θ,
{H(A1), H(A2), ..., H(Aq)} ∼ Dirichlet {αH0(A1), αH0(A2), ..., αH0(Aq)}.
For any set A,H(A) has a Beta distribution with meanH0(A) and varianceH0(A){1−
H0(A)}/α + 1. As a result, if α goes large, the DP will concentrate on its mean
distribution H0.
To be more precise about the what a random draw from a DP looks like, Sethu-
raman (1981, 1994) developed a constructive definition of the DP called the stick-






where vq ∼ H0 and δvq(·) is a dirac function with mass on vq. An infinite sequence
of weights {πq}∞q=1 is distributed according to a GEM (Griffiths-Engen-McCloskey)
process with concentration parameter α (Pitman and Yor, 1997): π|α ∼ GEM(α)
that is
π1 = v1, πq = (1− v1)(1− v2)...(1− vq−1)vq, q ≥ 2,
vq ∼ Beta(1, α).
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Dirichlet process mixture model (DPM) was first formalized by Antoniak (1974)
and Ferguson (1983) in which the DP was used as a prior over the distribution
of the parameters. Suppose ηi is distributed according to some distribution F (νi)
parameterized by νi: ηi|νi ∼ F (νi) and each νi is independently and identically drawn
from the Dirichlet process DP(αH0): νi|H ∼ H, H|(α,H0) ∼ DP(αH0). Hence,
we generate a Dirichlet process mixture for the distribution of ηi. Following the
perspective of stick-breaking process which constructs the DP with countably infinite
sum of atomic measures, DPM can be rebuilt as a mixture model. By introducing a
cluster variable di which is assigned a probability πq to be the integer q, the DPM
can be rewritten as
π|α ∼ GEM(α), νq|H0 ∼ H0,
di|π ∼ Mult(π), ηi|{νq}, di ∼ F (νdi). (1.5)
In literature, Dirichlet mixture process has been used extensively in different types
of modelling problems when conventional parametric priors would impose unreason-
ably stiff constraints on the distributional assumptions. In the context of density
estimation and clustering data, DPM received a lot of attention (Lo, 1984; Escobar
and West, 1995; Rasmussen, 2000; Neal, 2000). In the failure time modelling when
the support of the density is on the positive reals, Hanson (2006) pointed out that few
researches contributed to that topic and he proposed an AFT model with baseline
survival function modelled by Dirichlet process Gamma mixture. In chapter 3, we
assign the Dirichlet process Gamma mixture as a prior to the frailty distribution to
avoid the parametric assumption.
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Chapter 2
Regression analysis of bivariate current status
data under the Gamma-frailty proportional
hazards model using the EM algorithm
2.1 Introduction
Current status data commonly arise in many epidemiological, social, and medical
studies and it is characterized by the fact that the failure time of interest is not di-
rectly observed, but is known to occur either before or after an examination time.
In other words, the failure times are either left- or right-censored. We illustrate the
current status data with a couple of examples in the introduction chapter. We notice
that the statistical literature is replete with methods of analyzing current status data
pertaining to a single failure time of interest. Huang (1996) applied the proportional
hazards model to the univariate current status data to obtain the maximum likeli-
hood estimator and asymptotic variance matrix for regression parameter. Huang and
Rossini (1997) fit with the proportional odds model using sieve method. McMahan
et al (2013) developed an EM algorithm for the analysis of univariate current status
data .Some review of methods can be found in Huang and Wellner (1997); Jewell and
van der Laan (2003); Sun (2006); Ding-Geng Chen, et al.(2012).
The primary goal of this chapter is to develop a precise, flexible, and computation-
ally efficient method that can be used to analyze correlated bivariate current status
data under the Gamma-frailty PH model. To provide adequate modeling flexibility,
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the monotone splines of Ramsay (1988) are adopted to model the unknown condition-
al cumulative baseline hazard functions. Through a three-stage data augmentation
procedure, involving latent Poisson random variables, a novel EM algorithm is de-
rived for the purposes of model fitting. At each iteration of our algorithm the spline
coefficients are updated in closed form, with the regression parameters being updated
through solving a low-dimensional system of equations. Additionally, all of the ex-
pectations involved in the E-step of our algorithm are available in closed form. These
features allow our approach to be very computationally efficient, when compared to
other competing methods, especially for the analysis of large data sets as is illustrated
in our simulation and data analysis sections. Further our proposed technique is easy
to implement and robust to initialization.
The remainder is organized as follows. In Section 2.2, we present the Gamma-
frailty PH model, the observed data likelihood, and describe how monotone splines are
used to approximate the unknown conditional cumulative baseline hazard functions.
In Section 2.3, we present the derivation of our EM algorithm. In Section 2.4 we
illustrate the performance of our method through a simulation study and in Section
2.5 we present the results from a real data application. Section 2.6 concludes with a
summary and discussion.
2.2 Model, data, and likelihood.
Gamma-frailty PH model
Let T1 and T2 denote two failure times of interest. Under the Gamma-frailty PH
model the conditional cumulative hazard function for Tj, given the frailty η, can be
expressed as
Λj(t|x, η) = Λ0j(t) exp(x′βj)η, for j = 1, 2 (2.1)
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where η ∼ Ga(ν, ν), Λ0j is the conditional cumulative baseline hazard function, x is a
vector of covariates, and βj is the corresponding vector of regression parameters. This
model assumes that T1 and T2 are conditionally independent given the frailty term η.
Further, under the Gamma-frailty PH model the conditional cumulative distribution
function for Tj is given by Fj(t|x, η) = 1 − exp{−Λ0j(t) exp(x′βj)η}. Theoretically
for Fj(t|x, η) to be proper, Λ0j must be a nondecreasing function such that Λ0j(0) = 0
and limt→∞ Λ0j(t) =∞. The latter characteristic can be relaxed when one considers
a finite time domain; e.g., when conducting data analysis.
The Gamma-frailty PH model has several desirable properties. First, greater
modeling flexibility can be obtained since the conditional cumulative baseline hazard
functions (i.e., Λ0j for j = 1, 2) are not required to have a specific form. A discussion
on how to exploit this characteristic is provided in Section 2.3. Second, the marginal
and joint survival functions can be expressed in closed form as
Sj(t|x) = P (Tj > t|x) =
{
1 + ν−1Λ0j(t) exp(x′βj)
}−ν
, for j = 1, 2, (2.2)
S(t1, t2|x) = P (T1 > t1, T2 > t2|x)
=
{
1 + ν−1Λ01(t1) exp(x′β1) + ν−1Λ02(t2) exp(x′β2)
}−ν
,
respectively. Notice, it can be ascertained from (2.2) that Tj marginally follows a
generalized odds-rate hazards model (Scharfstein et al., 1998; Banerjee et al., 2007).
Consequently, the regression parameter βj can also be interpreted as the marginal
covariate effects on Tj under the generalized odds-rate hazards model. Finally, the
Gamma-frailty PH model also provides a closed-form expression for the correlation
between the two failure times in terms of Kendall’s τ with τ = (1+2ν)−1 (Hougaard,
2000; Wang and Ding, 2000; Sun et al., 2006). Kendall’s τ is defined as
τ = E[sign{(Ti1 − Tj1)(Ti2 − Tj2)}],
where (Ti1, Ti2) and (Tj1, Tj2) are two independent and identically distributed copies
of (T1, T2) and sign(·) is the usual sign function; i.e., this function takes values 1, 0,
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and -1 when the argument is positive, zero, and negative, respectively. It is important
to notice that under the Gamma-frailty PH model τ is a deterministic function of
ν. Therefore, the correlation structure (i.e., τ) between the two failure times can be
accurately estimated as long as as a good estimate of ν is available.
Data structure and observed likelihood function
In order to derive the observed data likelihood, we proceed under several common
assumptions as in Chen et al. (2009), Hens et al. (2009), and Wen and Chen (2011)
among others. In particular, we assume that the two failure times are subject to
univariate censoring at the observation time C, and moreover that Tj, given the
covariates, is independent of C, for j=1,2. Let δj = 1(Tj≤C) denote the censoring
indicator for Tj, where 1(·) denotes the usual indicator function; i.e., δj = 1 if the
failure time is left-censored and δj = 0 if it is right-censored. Consequently, the
observed data from a study consisting of n subjects can be succinctly expressed as
{(ci,xi, δi1, δi2), i = 1, ..., n}, where each (ci,xi, δi1, δi2) is an independent realization
of (C,x, δ1, δ2). Under the Gamma-frailty PH model and the aforementioned assump-






{1− Sj(ci|xi, ηi)}δij{Sj(ci|xi, ηi)}(1−δij)
]
g(ηi| ν, ν)dηi,
where Sj(t|xi, ηi) = 1 − Fj(t|xi, ηi) and g(·| ν, ν) is the probability density function
of a gamma random variable whose shape and rate parameters both equal ν. Using
the expressions that were presented in Section 2.1 for the marginal and joint survival















{1− S1(ci|xi)− S2(ci|xi) + S(ci, ci|xi)}, (2.3)
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where A1 = {i : δi1 = 0, δi2 = 0}, A2 = {i : δi1 = 0, δi2 = 1}, A3 = {i : δi1 = 1, δi2 =
0}, and A4 = {i : δi1 = 1, δi2 = 1}.
Monotone splines for Λ0j(t)
The unknown parameters in (2.3) involve the regression parameters βj and the non-
decreasing functions Λ0j, for j = 1, 2. It is important to note that Λ0j is an infinite
dimensional parameter. Following the work of Cai et al. (2011) and McMahan et al.
(2013), we propose to model these unknown functions using the monotone splines of





where Ijl(·), for l = 1, ..., k, is a monotone spline basis function and γjl is the corre-
sponding spline coefficient. In particular, the spline basis functions are nondecreasing
piecewise polynomials ranging from 0 to 1 and the spline coefficients are restricted to
be positive (i.e., γjl ≥ 0). Proceeding in this fashion ensures the monotonicity of Λ0j.
The basis functions of Ramsay (1988) are fully determined once their degree and
knot set have been specified. The degree of the basis functions controls the overall
smoothness of the splines; e.g., specifying the degree to be 1, 2, or 3 corresponds to
the splines being linear, quadratic, or cubic, respectively. The knot set is typically
comprised of an increasing sequence of values within the data range, and in conjunc-
tion with the degree controls the shape of the splines. Given the degree and knot
set the number of corresponding basis functions (k) is equal to the degree plus the
number of interior knots.
For our purposes, it is reasonable to use the same set of basis functions to model
both Λ01 and Λ02. That is to say, since both failure times are subject to the same
censoring time we are modeling both of the conditional cumulative baseline hazard
functions over the same time domain. Consequently, to simplify our notation we
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write Ijl(·), for j = 1, 2, as Il(·) from henceforward. It has been our experience that
specifying the degree of the basis functions to be either 2 or 3 provides adequate
smoothness. Further, we recommend that the knot set consist of a fixed number of
equally spaced points between the minimum and maximum of the censoring times.
Model selection criteria, such as Akaike information criterion (AIC) or the Bayesian
information criterion (BIC), can be used to determine the appropriate number of
knots, as was demonstrated in Rosenberg (1995) and McMahan et al. (2013). An
alternate approach would be to treat both the number and position of the knots
as unknown parameters and optimize over them according to some selection crite-
rion as in Shen (1988) or use Bayesian reversible jump Markov chain Monte Carlo
method (Green, 1995). Methods based on this strategy are usually computationally
burdensome and time consuming.
2.3 The proposed method
A data augmentation
In lieu of the monotone spline representation of the conditional cumulative baseline
hazard functions, the unknown parameters in (2.3) are θ = (β′1,β′2,γ ′1,γ ′2, ν)′, where
γj = (γj1, . . . , γjk)′ for j = 1, 2. Consequently, one could obtain an estimator of θ
by directly maximizing the observed data likelihood; i.e., the maximum likelihood
estimate (MLE) could be obtained as θ̂ = argmaxθLobs(θ). However, numerically
maximizing (2.3) with respect to θ is challenging because those spline coefficients are
constrained to be nonnegative. From our experience, it is very difficult to set up good
initial values for this constrained optimization , and common numerical optimization
techniques including Newton related algorithms fail to provide converged results. To
obviate these difficulties, we have developed a novel EM algorithm for the purposes
of obtaining the MLE of θ.
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The derivation of our proposed EM algorithm relies on a three-stage data aug-
mentation involving latent Poisson random variables. In the first stage we introduce
the individual frailty terms (i.e., ηi for i = 1, ..., n) as latent random variables, and







{1− Sj(ci|xi, ηi)}δij{Sj(ci|xi, ηi)}(1−δij). (2.5)
The second stage involves relating the censoring indicator δij to a latent Poisson
random variable zij, where zij|ηi ∼ P{·|Λ0j(ci) exp(x′iβj)ηi} and P(·|a) denotes the
cumulative distribution function of the Poisson distribution with mean a. Conse-












In the final stage, we decompose each zij as the sum of k independent latent Poisson
random variables; i.e., we let zij =
∑k
l=1 zijl, where zijl|ηi ∼ P{·|γjlIl(ci) exp(x′iβj)ηi}
for l = 1, ..., k. At this layer, we arrive at the conditional likelihood that we refer to















It is important to notice that by integrating all of the zijl’s out of (2.7) one would
obtain (2.6), similarly integrating all of the zij’s out of (2.6) results in (2.5), and finally
integrating all of the ηi’s out of (2.5) leads back to the observed data likelihood.
The EM algorithm
To develop our EM algorithm we will view (2.7) as our complete data likelihood, in
which the latent variables (i.e., the zijl’s, zijl’s, and ηi’s) are viewed as missing. The
E-step in our EM algorithm involves taking the expectation of logLc(θ) with respect
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to all of the latent variables conditional on the observed data, which we denote by
























{log(γjl) + x′iβj}E(zijl)− γjlIl(ci) exp(x′iβj)E(ηi)
]
,




and H3(θ(m)) is a function of θ(m) but is free of θ. Notice, for notational brevity we
have suppressed the conditioning arguments in the above expectations; i.e., it is un-
derstood that E(·) = E(·|D,θ(m)). All of the conditional expectations in H1(θ,θ(m))
and H2(θ,θ(m)) have closed form expressions and are provided in the appendix, a-
long with a brief sketch of their derivation. The M-step in our algorithm then finds
θ(m+1) as the maximizer of Q(θ,θ(m)); i.e., θ(m+1) = argmaxθQ(θ,θ
(m)). First we
note that H1(θ,θ(m)) is free of ν, consequently one can obtain ν(m+1) by directly
maximizing H2(θ,θ(m)), and it is easy to show that this maximizer is unique. Sim-
ilarly, H2(θ,θ(m)) is free of the regression parameters and spline coefficients, so we
need only maximize H1(θ,θ(m)) with respect to the βj’s and γj’s. To this end, we













−1E(zijl)− Il(ci) exp(x′iβj)E(ηi), for l = 1, ..., k and .
Setting ∂H1(θ,θ(m))/∂γjl equal to 0 and solving for γjl we obtain the maximizer as








for l = 1, ..., k and j = 1, 2. To find β(m+1)j , one would then replace γjl by (2.8) in the
system of equations given by ∂H1(θ,θ(m))/∂βj = 0 and solve for β
(m+1)
j . In doing




jl (β(m+1)), for l = 1, ..., k
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and j = 1, 2. Notice the expression of γ(m+1)jl automatically satisfies the nonnegative
constraint for each j and l.
We now succinctly state our EM algorithm. First, initialize θ(0) and set m = 0,
then repeat the following steps until convergence:












2. Calculate γ(m+1)jl = γ
∗(m)
jl (β(m+1)), for l = 1, . . . , k and j = 1, 2.
3. Obtain ν(m+1) = argmaxνH2(θ;θ(m)) and update m = m+ 1.
Denote the final value θ(m+1) at convergence as θ̂. It is easy to show that θ̂ satisfies
the score equations associated with the observed data likelihood, and it is therefore
the MLE of θ.
Variance Estimate
In order to draw inference, an estimate of the variance-covariance matrix, Σ, of
θ̂ has to be obtained. Since the observed data likelihood exists in closed form, a
natural estimator of Σ would be {I(θ̂)}−1, where I(θ) is the observed information
matrix; i.e., I(θ) = ∂2 logLobs/∂θ∂θ′. As one might expect, analytically expressing
the mixed partial derivatives involved in I(θ) can be quite tedious, and likewise
evaluating them can be computationally burdensome. A plausible alternative would
involve using Louis’s method to evaluate I(θ̂), but this approach is also fraught with
the same complexities. To circumvent these issues, we suggest implementing the
approach outlined in Zeng et al. (2007) and Lin and Wang (2010). In particular, we
propose to approximate the (s, l)th element of I(θ̂) using
Is,l(θ̂) = h−2n
[
log{L(θ̂ + hn~es − hn~el)} − log{L(θ̂ + hn~es)} − log{L(θ̂ − hn~el)}+ log{L(θ̂)}
]
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where hn is a tuning constant of order n−1/2 and ~es is a binary vector whose sth
element is 1 with all others being 0. Proceeding in this fashion provides a straight-
forward, reliable, and efficient method of estimating Σ.
2.4 Simulation Study
In order to evaluate the finite sample performance of the proposed methodology, sev-
eral extensive simulation studies were conducted. In particular, three scenarios were
considered: Scenario (1) considers the situation in which the assumed model (i.e., the
Gamma-frailty PH model) is correctly specified; Scenario (2) investigates the situa-
tion in which the frailty distribution is misspecified; and Scenario (3) examines the
situation in which the two failure times share both a common cumulative baseline
hazard function and set of regression parameters. The two former scenarios investi-
gate the performance of the proposed methodology across a wide variety of settings,
while the latter allows for a direct comparison between the proposed approach and
the methodology presented in Wen and Chen (2011).
Under Scenario (1), the following models for T1 and T2 were considered,
Fj(t|x1, x2, η) = 1− exp{−Λ0j(t) exp(βj1x1 + βj2x2)η}, for j = 1, 2,
where x1 ∼ Bernoulli(0.5), x2 ∼ N(0, 0.52), η ∼ G(1, 1), Λ0j(t) = log(1 + t) + t3/2,
and each of the regression parameters took on values 0.5 or −0.5, with β11 = β21
and β12 = β22. The censoring time C was generated from a truncated exponential
distribution E(λ) with support (0, 10). In order to examine different censoring rates,
several values of the rate parameter were considered; i.e., λ ∈ {1, 2, 5}. The censoring
indicator, δj, was sampled according to a Bernoulli distribution with success prob-
ability F (C|x1, x2, η), for each j. Proceeding in this fashion circumvents sampling
the failure times directly. For each of the regression parameter configurations we
generated 500 data sets, each containing n = 200 observations.
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To fit the proposed model, the degree of the monotone splines was specified to be 3
and a knot set consisting of 5 equally spaced knots within the minimum and maximum
of the censoring times for each data set was considered. The EM algorithm outlined
in Section 2.2 was then used to estimate both the regression and spline coefficients as
well as the frailty variance parameter for each of the data sets. Under all simulation
settings, the regression parameters were initialized to be 0, the initial value of the
frailty variance ν was taken to be 2, and the initial values of the spline coefficients were
randomly generated according to an E(1) distribution. Convergence of the algorithm
was declared when all of the absolute differences between consecutive updates for the
regression parameters and the frailty variance were less than 10−4. To approximate
the observed information matrix, the tuning parameter hn was taken to be 0.01n−1/2.
Table 2.1 and 2.2 summarizes the parameter estimates resulting from the proposed
approach, across a variety of the considered simulation settings. In particular, the
settings chosen for these two tables provide a summary of the performance of the
proposed methodology across a variety of censoring rates. The summarized results in
Table 2.1 and 2.2 include the average of the 500 MLEs minus their true value (BIAS),
the average of the estimated standard errors (ESE), the sample standard deviation of
the 500 MLEs (SSD), and empirical coverage probabilities associated with 95% Wald
confidence intervals (CP95). As seen in Table 2.1 and 2.2, the parameter estimates
exhibit little, if any, evidence of bias, the averaged standard errors are in agreement
with the sample standard deviations of the MLEs, and the coverage probabilities are
close to their nominal levels, for all the regression parameters and the frailty variance
parameter under all considered configurations.
Scenario (2) was aimed at investigating how sensitive the proposed techniques
is to the gamma frailty assumption. This simulation considered exactly the same
model specifications as in Scenario (1), with the exception that a mixture log-normal
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distribution was specified for the frailty term; i.e.,
f(η) = 0.25LN (−1, 2) + 0.50LN (−1, 0.61) + 0.25LN (0.5, 0.39),
where LN (µ, σ2) denotes the log-normal distribution with location parameter µ and
scale parameter σ. The proposed model was again fit using the same settings as were
described in Scenario (1). Table 2.3 and 2.4 presents a summary of the regression
parameter estimates obtained by the proposed methodology for the same simulation
configurations as were considered in Table 2.3 and 2.4 . These results again exhibit
little, if any, bias in the point estimates, the average estimated standard errors remain
in agreement with the sample standard deviation of the MLEs, and the coverage
probabilities are again close to 0.95 for all regression parameters, under all considered
settings. This suggests that our proposed methodology can provide accurate point
and variance estimates for all of the regression parameters even when the frailty
distribution is egregiously misspecified; i.e., the proposed methodology is robust to
the misspecification of the frailty distribution.
Scenario (3) was designed to compare the proposed approach with the method-
ology presented in Wen and Chen (2011). In particular, the technique proposed by
Wen and Chen (2011) was designed to analyze clustered current status data under
the Gamma-frailty PH model. This method can also be used to analyze bivariate
current status data, under the assumption that the two correlated failure times share
both a common cumulative baseline hazard function and set of regression coefficients.
In order to facilitate this comparison, slight modifications of the methods presented
in Section 2.4 were made so that these two techniques could be compared. In par-
ticular, the modifications allow for different censoring times for the two events and
require β1 = β2 = β and γ1 = γ2 = γ. Simulation settings were chosen to emulate
the studies conducted in Wen and Chen (2011). Specifically, the common cumula-
tive baseline hazard function was taken to be Λ0(t) = t, the frailty distribution was
specified to be G(1, 1), and the two censoring times were independently generated
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according to U(0,1). The settings for the regression coefficients and covariate distribu-
tions were specified to be the same as in Scenario (1). Convergence for both methods
was declared when the difference between consecutive updates of the parameters of
interest were less than 10−5. This stricter convergence criterion was chosen because
it was the default value used in Wen and Chen’s Matlab package for implementing
their method. Table 2.5 summarizes the parameter estimates obtained by the two
competing techniques. In summary, both methods seem to perform well; however,
the proposed method seems to perform slightly better; i.e., the proposed technique
results in parameter estimates that exhibit both a smaller bias and variance.
In summary, through simulation the proposed methodology has been shown to
be very reliable for the purposes of analyzing bivariate current status data. Further,
through the derivation of a novel EM algorithm, the proposed model can be fit at a
minimal computational expense; e.g., the average time required for the EM algorith-
m to both converge and estimate the variance-covariance matrix under Scenarios (1)
and (2) was approximately 3 to 4 seconds per data set. Time trials were also con-
ducted between the proposed approach and the methodology presented in Wen and
Chen (2011). The results from these additional studies, which are provided in Table
2.6 , indicate that the proposed method is far more computationally efficient when
compared to this competing technique, especially for larger sample sizes. For exam-
ple, when N = 2000 the proposed approach is approximately 470 times faster than
the methodology proposed in Wen and Chen (2011). This finding suggests that our
methodology, unlike many competing approaches, can be used to analyze relatively
large data sets in a timely fashion.
2.5 An application
Now we apply the proposed EM algorithm to a set of bivariate current status data
we introduced in the introduction part. The initial analysis of this data set, which
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was reported in Allright et al. (2000), identified risk factors associated with HIV and
hepatitis B using logistic regression; i.e., these authors treated the HBV and HIV
infection statuses of the individuals as binary responses and modeled each response
individually. As both of these infection can be asymptomatic, many afflicted subjects
were likely infected long before the time of the survey, a feature that was not accounted
for in the original analysis. Further, the original analysis of this data modeled the
incidence of HBV and HIV separately, and therefore cannot estimate the correlation
that natural exists between these two diseases. In what follows, we will focus on
jointly modeling the infection times of these diseases, both of which are not directly
observed but are rather known to be either left- or right-censored relative to the age
of the participant at the time of testing. Proceeding in this fashion will allow us to
estimate the cumulative incidence of these two diseases, assess different risk factors,
and quantify the statistical correlation between the two diseases. The censoring time
is taken to be the participants age at the time of the survey. In total, there were 865
prisoners who provided completed questionnaires and were tested for both diseases.
Table 2.7 summarizes the detailed information of the data sets. Figure 2.1 displays
the histogram for the age of the prisoners.
In the analysis, we considered the following covariates: whether the participants
had ever been treated for a sexually transmitted disease (TreatSTD), participated in
intravenous drug use (EVRINJ), smoked heroin (SMHeroin), had a sexual relation-
ship with another man before/after committal (ASM/ASMIP), and whether they
used condoms during heterosexual intercourse (UseCondoms) as well as the amount
of time the participants spent in prison in the past 10 years (TSL10Y). With the
exception of TSL10Y, all of the aforementioned covariates are binary. To implement
our proposed methodology, we took the degree of the monotone splines to be 3 and
tried several knot sets each consisting of m equally spaced interior knots. It was ob-
served that the estimation results are relatively robust to the number of knots. Table
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2.9 presents AIC and BIC values corresponding to different values of m. Since both
AIC and BIC are smallest when m = 5, we chose our final model to be the one that
makes use of 5 interior knots to approximate the the conditional cumulative baseline
hazards function. For the purpose of comparison, we also performed a complimentary
univariate analysis of this data. More specifically, using the R function glm we fit
a binary regression model for each of the diseases, separately, using a cloglog link
function. This regression analysis uses the age at the time of testing as a continuous
covariate and results in a special parametric PH model with log(Λ0(t)) = ct for some
unknown constant c. The cloglog link is chosen because the regression parameters
can be interpreted as log hazard ratios, which are comparable to those provided by
our joint analysis.
Table 2.8 summarizes the estimates of the regression parameters obtained from our
joint analysis under our final model (i.e., when m = 5) and compares these results
to the estimates obtained from the univariate binary regression analysis. Both of
these techniques identify the same set of significant risk factors; i.e., participating in
intravenous drug use increases a subjects risk of contracting both of these diseases, the
risk of contracting HIV increases with the amount of time spent in prison, and condom
use decreases the risk of contracting HIV. However, it is worthwhile to point out that
our joint modeling approach is able to identify these covariates at a higher level of
statistical significance when compared to the estimates obtained by the univariate
approach.
Further, the joint analysis yields an estimate of ν to be ν̂ = 0.61 with standard
error 0.09. This leads to an estimate of Kendall’s concordance τ between the two
failure times to be τ̂ = 0.45 with a standard error of 0.037. The standard error of τ̂
was obtained through an application of the delta method. This suggests that there
is a moderate correlation between the two failure times. In comparison, it is not
possible to estimate the correlation between the onset time of HBV and HIV using
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the univariate modeling approach. Our proposed model also allows us to estimate
the marginal cumulative incidence 1 − Sj(t|x) of HBV and HIV for subgroups of
prisoners using equation (2). For example, Figure 2.2 presents the estimated marginal
cumulative incidences of HBV for the baseline group (i.e., controlling all covariates
equal to 0) and for those subjects who had participated in intravenous drug use (still
controlling all other covariates equal to 0) from our joint analysis as well as the
corresponding curves from the binary regression. It is reasonable that the estimated
baseline cumulative incidences are similar from the two methods. However, there
is a substantial difference between the estimated curves for the intravenous drug
users from the two methods. The curve from our joint analysis is believed to be more
accurate due to borrowing information between the correlated failure times in the joint
modeling and more flexible semiparametric modeling in the marginal distributions.
2.6 Concluding remark
In this chapter, we develop a computationally efficient method of analyzing bivariate
current status data under the Gamma-frailty PH model, by generalizing the work of
McMahan et al. (2013). Our formulation approximates the unknown conditional cu-
mulative baseline hazard functions with monotone splines, which significantly reduces
the number of unknown parameters while maintaining adequate modeling flexibility.
A three-stage data augmentation procedure is used to facilitate the derivation of our
EM algorithm. The resulting algorithm involves solving a low-dimensional system of
equations for updating the regression parameters and the frailty variance parameter,
with the spline coefficients being updated in closed form. All of the expectations
involved in the EM algorithm can be expressed in closed form. The EM algorithm is
easy to implement and enjoys fast convergence. Through simulation, we have shown
that the proposed method accurately and efficiently estimates all of the unknown
parameters (and thus the correlation between the two failure times) when the model
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is correctly specified and that the estimation of the regression parameters is robust
to the misspecification of the frailty distribution.
The approach of Chen et al. (2009) can also be used to analyze bivariate current
status data. Specifically their approach is based on an EM algorithm under a frailty
PH model with correlated normal frailties. The EM algorithm proposed by these
authors is definitively more complicated than ours since it uses a series of numeri-
cally intensive approximations to evaluate the conditional expectations involved in
the E-step of their algorithm. Such numerical approximations cause not only com-
putational burdens but convergence problems when a strict convergence criteria is
used. Consequently, this method, because of its computational nature, may not be
appropriate for analyzing large data sets, due to the time required to complete model
fitting. On the other hand, the approach of Chen et al. (2009) allows for correlated
normal frailties for multivariate current status data, while our work focuses only on
bivariate current status data. Our method can naturally be extended to multivari-
ate data with a shared frailty, but extensions allowing for correlated frailties do not
appear to be straightforward.
Topics for future work include the development of hypothesis testing procedures
that can be used to evaluate our modeling assumptions. For example, in our data
application it may or may not be reasonable to assume that the infection times are
conditionally independent of the censoring times, given the covariates. Consequently,
the development of a formal method of testing this assumption would be discernibly
beneficial. Further, for situations in which the aforementioned modeling assumption
does not hold, we plan to extend our proposed methodology to allow for informative
censoring, a modeling attribute that would extend the utilitarian nature of our work
to many other epidemiological and medical research areas.
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Figure 2.1 The histogram of the age.
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baseline grop (logistic regression)
drug injection group (logistic regression)
baseline group (joint analysis)
drug injection group (joint analysis)
Figure 2.2 The estimated marginal cumulative incidence functions of hepatitis B
for the baseline group (controlling all covariates equal to 0) and drug injection
subgroup (controlling all other covariates equal to 0).
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Figure 2.3 The estimated marginal cumulative incidence functions of hiv for the
baseline group (controlling all covariates equal to 0) and other significant risk factor
subgroups (controlling all other covariates equal to 0).
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Table 2.1 Simulation results under Scenario (1) with different left-censoring rates
(LR). Summarized results include the average of the 500 MLEs minus their true
value (BIAS), the sample standard deviation of the 500 MLEs (SSD), the average of
the estimated standard errors (ESE), and empirical coverage probabilities associated
with 95% Wald confidence intervals (CP95), for each parameter.
βj1 = −0.5 and βj2 = 0.5 βj1 = 0.5 and βj2 = 0.5
LR BIAS SSD ESE CP95 LR BIAS SSD ESE CP95
45.2% β̂11 0.011 0.347 0.348 0.952 54.3% β̂11 -0.007 0.354 0.346 0.936
β̂12 0.012 0.340 0.352 0.956 β̂12 -0.005 0.370 0.351 0.942
45.2% β̂21 -0.001 0.335 0.350 0.952 54.1% β̂21 0.013 0.330 0.344 0.968
β̂22 0.030 0.374 0.352 0.946 β̂22 -0.014 0.355 0.350 0.954
ν̂−1 0.034 0.336 0.367 0.982 ν̂−1 -0.018 0.302 0.346 0.982
30.9% β̂11 -0.040 0.366 0.364 0.952 39.9% β̂11 0.011 0.361 0.350 0.956
β̂12 0.021 0.395 0.372 0.946 β̂12 0.026 0.355 0.355 0.952
30.8% β̂21 -0.029 0.368 0.363 0.946 39.7% β̂21 0.010 0.363 0.352 0.946
β̂22 0.038 0.384 0.372 0.956 β̂22 0.044 0.354 0.355 0.966
ν̂−1 0.077 0.416 0.414 0.978 ν̂−1 0.039 0.355 0.385 0.992
16.2% β̂11 -0.037 0.482 0.459 0.934 22.7% β̂11 0.046 0.410 0.403 0.954
β̂12 0.037 0.532 0.460 0.928 β̂12 0.048 0.410 0.405 0.956
16.0% β̂21 -0.060 0.507 0.457 0.906 22.7% β̂21 0.010 0.400 0.403 0.942
β̂22 0.017 0.487 0.458 0.926 β̂22 0.014 0.406 0.402 0.952
ν̂−1 0.187 0.716 0.635 0.974 ν̂−1 0.088 0.539 0.509 0.976
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Table 2.2 Simulation results under Scenario (1) with different left-censoring rates
(LR). Summarized results include the average of the 500 MLEs minus their true
value (BIAS), the sample standard deviation of the 500 MLEs (SSD), the average of
the estimated standard errors (ESE), and empirical coverage probabilities associated
with 95% Wald confidence intervals (CP95), for each parameter.
βj1 = −0.5 βj2 = −0.5 βj1 = 0.5 βj2 = −0.5
LR BIAS SSD ESE CP95 LR BIAS SSD ESE CP95
45.1% β̂11 -0.006 0.324 0.345 0.965 54.1% β̂11 -0.006 0.335 0.347 0.956
β̂12 0.005 0.361 0.351 0.942 β̂12 -0.028 0.356 0.348 0.943
44.8% β̂21 0.002 0.341 0.345 0.945 54.1% β̂21 -0.012 0.333 0.347 0.965
β̂22 -0.029 0.364 0.350 0.948 β̂22 -0.003 0.346 0.348 0.945
ν̂−1 0.022 0.332 0.361 0.979 ν̂−1 -0.003 0.288 0.334 0.993
31.1% β̂11 -0.001 0.366 0.366 0.953 39.6% β̂11 0.033 0.334 0.354 0.963
β̂12 -0.011 0.374 0.368 0.96 β̂12 -0.035 0.365 0.356 0.944
31.0% β̂21 -0.030 0.377 0.366 0.949 39.7% β̂21 0.030 0.341 0.352 0.957
β̂22 -0.020 0.380 0.367 0.940 β̂22 -0.009 0.334 0.350 0.957
ν̂−1 0.050 0.423 0.422 0.983 ν̂−1 0.043 0.369 0.377 0.980
16.20% β̂11 -0.053 0.480 0.452 0.945 22.4% β̂11 0.048 0.414 0.405 0.937
β̂12 -0.046 0.488 0.455 0.946 β̂12 -0.043 0.421 0.405 0.938
16.11% β̂12 -0.031 0.477 0.454 0.935 22.7% β̂12 0.015 0.412 0.407 0.948
β̂22 -0.045 0.467 0.455 0.944 β̂22 -0.038 0.412 0.403 0.942
ν̂−1 0.181 0.650 0.637 0.980 ν̂−1 0.134 0.553 0.511 0.981
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Table 2.3 Simulation results under Scenario (2) with different left-censoring rates
(LR) when the gamma frailty distribution is misspecified. Summarized results
include the average of the 500 MLEs minus their true value (BIAS), the sample
standard deviation of the 500 MLEs (SSD), the average of the estimated standard
errors (ESE), and empirical coverage probabilities associated with 95% Wald
confidence intervals (CP95), for each parameter.
βj1 = −0.5 and βj2 = 0.5 βj1 = 0.5 and βj2 = 0.5
LR BIAS SSD ESE CP95 LR BIAS SSD ESE CP95
43.3% β̂11 0.034 0.340 0.340 0.956 52.1% β̂11 -0.020 0.327 0.332 0.948
β̂12 0.005 0.358 0.348 0.948 β̂12 0.013 0.339 0.335 0.956
43.4% β̂21 0.025 0.342 0.337 0.948 52.2% β̂21 -0.030 0.344 0.334 0.950
β̂22 0.013 0.348 0.346 0.954 β̂22 0.002 0.332 0.336 0.950
29.0% β̂11 -0.015 0.391 0.370 0.952 29.2% β̂11 -0.006 0.335 0.357 0.968
β̂12 -0.004 0.398 0.377 0.938 β̂12 -0.009 0.368 0.362 0.938
37.7% β̂21 -0.042 0.399 0.372 0.940 37.6% β̂21 0.013 0.375 0.360 0.930
β̂22 0.011 0.394 0.377 0.956 β̂22 0.006 0.361 0.355 0.958
15.0% β̂11 0.005 0.485 0.471 0.944 21.1% β̂11 0.017 0.426 0.414 0.946
β̂12 0.060 0.504 0.480 0.944 β̂12 0.022 0.428 0.417 0.958
15.0% β̂21 0.009 0.486 0.464 0.938 21.4% β̂21 0.011 0.444 0.420 0.948
β̂22 0.029 0.505 0.478 0.944 β̂22 0.034 0.426 0.415 0.950
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Table 2.4 Simulation results under Scenario (2) with different left-censoring rates
(LR) when the gamma frailty distribution is misspecified. Summarized results
include the average of the 500 MLEs minus their true value (BIAS), the sample
standard deviation of the 500 MLEs (SSD), the average of the estimated standard
errors (ESE), and empirical coverage probabilities associated with 95% Wald
confidence intervals (CP95), for each parameter.
βj1 = −0.5 and βj2 = −0.5 βj1 = 0.5 and βj2 = −0.5
LR BIAS SSD ESE CP95 LR BIAS SSD ESE CP95
43.1% β̂11 -0.009 0.333 0.335 0.943 52.3% β̂11 -0.005 0.346 0.332 0.947
β̂12 -0.001 0.360 0.342 0.937 β̂12 -0.005 0.345 0.334 0.953
43.1% β̂21 0.020 0.333 0.333 0.947 52.5% β̂21 -0.010 0.317 0.332 0.949
β̂22 -0.011 0.370 0.342 0.953 β̂22 0.003 0.345 0.336 0.953
29.0% β̂11 -0.017 0.372 0.381 0.947 29.2% β̂11 -0.025 0.365 0.352 0.941
β̂12 -0.007 0.387 0.380 0.943 β̂12 -0.0163 0.373 0.352 0.944
37.7% β̂21 0.009 0.380 0.373 0.947 37.5% β̂21 0.007 0.355 0.352 0.946
β̂22 -0.009 0.383 0.380 0.959 β̂22 -0.0164 0.352 0.351 0.949
15.1% β̂11 -0.056 0.476 0.462 0.932 21.3% β̂11 -0.009 0.445 0.417 0.936
β̂12 -0.031 0.482 0.471 0.945 β̂12 -0.0536 0.463 0.416 0.924
15.0% β̂21 -0.071 0.531 0.467 0.9050 21.2% β̂21 0.000 0.418 0.421 0.943
β̂22 -0.036 0.495 0.475 0.939 β̂22 -0.014 0.425 0.416 0.966
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Table 2.5 Simulation results from the proposed method and the approach of Wen
and Chen (2011) under Scenario (3). Summarized results include the average of the
500 MLEs minus the true value (BIAS), the sample standard deviation of the 500
MLEs (SSD), the average of the estimated standard errors (ESE), and empirical
coverage probabilities associated with 95% Wald confidence intervals (CP95), for
each parameter.
Proposed method Wen and Chen (2011)
β1 β2 BIAS SSD ESE CP95 BIAS SSD ESE CP95
0.5 -0.5 β̂1 0.018 0.232 0.230 0.954 0.043 0.247 0.240 0.954
β̂2 -0.010 0.246 0.230 0.936 -0.035 0.261 0.238 0.934
ν̂−1 0.019 0.404 0.427 0.990 0.097 0.445 0.461 0.966
0.5 0.5 β̂1 0.024 0.239 0.231 0.950 0.045 0.255 0.241 0.952
β̂2 0.018 0.234 0.232 0.942 0.038 0.245 0.245 0.944
ν̂−1 0.048 0.438 0.428 0.990 0.120 0.473 0.473 0.956
-0.5 0.5 β̂1 -0.023 0.244 0.257 0.950 -0.048 0.261 0.258 0.942
β̂2 -0.020 0.265 0.250 0.950 0.060 0.275 0.267 0.954
ν̂−1 0.119 0.522 0.542 0.976 0.214 0.572 0.594 0.994
-0.5 -0.5 β̂1 -0.025 0.253 0.257 0.954 -0.044 0.260 0.255 0.952
β̂2 0.035 0.261 0.253 0.948 -0.040 0.280 0.257 0.944
ν̂−1 0.058 0.525 0.534 0.990 0.124 0.570 0.569 0.980
Table 2.6 Average convergence time (in seconds) associated with the proposed
methodology and the approach of Wen and Chen (2011) per data set.
Approach n = 100 n = 200 n = 500 n = 1000 n = 2000
Wen and Chen 18.5 26.8 163.8 1416.1 11937
Proposed 12.1 11.2 27.1 35.4 24.7
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Table 2.7 The summarized demographic and covariate information including the
frequency of all binary covariate variables and the responses. 0 indicates the









Response HBV 792(91.56%) 73(8.44%)
HIV 848(98.03%) 17(1.97%)
Table 2.8 Estimated covariates effects, their standard errors, the corresponding
95% confidence intervals and the p-value from the significance test. The covariates
included in the both models are: ever treated for sexually transmitted infection;
injecting drug use; Smoking heroin; time spent in prison in the past 10 years; ever
had sex with a man; ever had sex with a man inside prison; use condoms during
heterosexual intercourse; age at the survey.
s
Logistic regression Gamma frailty PH model
Covariate Point S.E. 95%CI p-value Point S.E. 95%CI p-value
hepatitis B TreatSTD 0.53 0.34 (-0.13,1.19) 0.12 0.56 0.31 (-0.06,1.17) 0.07
EVRINJ 3.71 0.59 (2.56,4.85) 0 3.90 0.43 (3.05,4.75) 0
SMHeroin 0.07 0.35 (-0.62,0.76) 0.84 0.07 0.32 (-0.56,0.70) 0.83
TSL10Y 0.00 0.15 (-0.29,0.29) 1 0.01 0.11 (-0.20,0.22) 0.93
ASM 0.67 0.86 (-1.01,2.36) 0.44 0.80 0.90 (-0.97,2.57) 0.37
ASMIP -1.06 1.33 (-3.67,1.55) 0.43 -1.30 1.35 (-3.95,1.35) 0.34
UseCondom -0.32 0.29 (-0.88,0.25) 0.27 -0.27 0.25 (-0.77,0.23) 0.28
Age 0.10 0.02 (0.06,0.13) 0 - - - -
HIV TreatSTD 0.55 0.61 (-0.64,1.74) 0.36 0.57 0.46 (-0.32,1.47) 0.22
EVRINJ 2.54 0.86 (0.86,4.23) 0.0031 2.57 0.54 (1.48,3.65) 1.94× 10−4
SMHeroin -0.66 0.66 (-1.95,0.63) 0.32 -0.66 0.47 (-1.57,0.26) 0.16
TSL10Y 1.51 0.66 (0.22,2.80) 0.02 1.35 0.12 (1.12,1.59) 0
ASM -0.19 1.74 (-3.61,3.22) 0.91 -0.39 1.41 (-3.16,2.38) 0.78
ASMIP 1.18 1.75 (-2.24,4.60) 0.50 1.03 1.39 (-1.69,3.75) 0.46
UseCondom -1.86 0.55 (-2.94,-0.79) 0.0007 -1.84 0.38 (-2.58,-1.10) 1.28× 10−6
Age 0.10 0.04 (0.03,0.17) 0.01 - - - -
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Table 2.9 Estimation of the significant risk factors effect as well as their standard
deviations with different number of knots; the last two column are AIC and BIC.
Hepatitis B HIV
knots EVRINJ EVRINJ TSL10Y UseCondom ν AIC BIC
3 4.03(0.42) 2.34(0.52) 1.42(0.11) -1.77(0.36) 0.56(0.08) 7217.59 7327.13
4 4.09(0.42) 2.22(0.50) 1.42(0.11) -1.72(0.36) 0.48(0.06) 7194.40 7313.46
5 3.90(0.43) 2.57(0.54) 1.35(0.12) -1.84(0.38) 0.61(0.09) 7101.23 7229.83
6 4.19(0.42) 2.38(0.52) 1.29(0.11) -1.76(0.38) 0.49(0.06) 7281.98 7420.10
7 4.10(0.41) 2.19(0.49) 1.31(0.11) -1.71(0.35) 0.47(0.06) 7208.64 7356.24
10 4.03(0.51) 2.27(0.79) 1.28(0.17) -1.73(0.56) 0.54(0.26) 7209.78 7386.01
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Chapter 3
Bayesian regression analysis of bivariate
current status data
3.1 Introduction
In the this chapter, we develop an easy-to-implement Bayesian estimation method to
analyze bivariate current status data under the Gamma-frailty PH model. We use the
same modeling techniques as in chapter 2 such as the monotone spline approximation
and the data augmentation through Poisson latent variables. In section 3.2, we
propose an efficient Gibbs sampler under Gamma-frailty PH model involving only
easy-to-facilitate posterior computations. In section 3.3 we provide a Dirichlet process
gamma mixture prior for the frailty distribution so that we can allow for an unknown
distribution for frailty. We develop a Gibbs sampler based on exact block approach.
Section 3.4 shows the simulation performance and section 3.5 applies the methods to
the same real-life data as in chapter 2.
3.2 Bivariate Gamma-frailty PH model
A Gibbs sampler is a MCMC (Markov chain Monte Carlo) algorithm to approximate
the joint distribution of all variables by sampling the variables sequentially from their
univariate conditional distributions. It requires to have a posterior distribution for
each unknown parameter. The three-staged augmentation scheme developed in the
previous chapter does a great favor in obtaining the common parametric distributions
in the posterior computation. It substantially reduces the computation effort and
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leads the MCMC easy to facilitate. The following MCMC algorithm is developed
based on the augmented likelihood (2.7).
Prior and posterior computation
We assign conditionally independent exponential priors Exp(λj) for the spline coeffi-
cients γjls and take a gamma distribution G(aλ, bλ)for λj. We use the shrinkage priors
for the spline coefficients to avoid the over-fitting problem when applying too many
knots. We adopt independent priors for each component of βj which π(·) = N(µj, σ2j )
and we use the Exp(1) as the prior for the variance parameter ν of gamma frailty
distribution. The adaptive rejection Metropolis sampling (ARMS) (Gilks and Wild,
1992) is appropriate and convenient to sample βj and v since their posterior densities
are log-concave. The MCMC algorithm iterates through the following steps:




for zij > 0 if δij = 1
and {zijl}kl=1 ∼M
{
zij, (pij1, pij2, ..., pijk)
}
whereM denotes a multinomial distribution and pijl = γjlIl(ci)/
∑k
l=1 γjlIl(ci)
for l = 1, ...k, i = 1, 2, ...n, j = 1, 2.
2. Sample γjl ∼ G
{
1 +∑ni=1 zijl, λj +∑ni=1 Il(ci) exp(x′iβj)ηi}.
Sample the λj ∼ G(aλ + k, bλ +
∑k
l=1 γjl).
3. Sample each ηi from G
[























We can observe from the above algorithm that the procedure is efficient and all full
conditionals have simple closed forms except for βj and ν, which can be updated by
ARMS. In the simulation section we observe the good performance of this Bayesian
method as well as the good rate of convergence and mixing.
3.3 Dirichlet Process Gamma Mixture
Gamma frailty model gives us several promising properties but we concern about the
validity of the assumption for the frailty distribution. As introduced in chapter 1,
Dirichlet process mixture is widely used in modeling the unknown distributions. In
this section, to relax the gamma frailty assumption, we assign the Dirichlet process




where H is a random distribution drawn from the Dirichlet Process DP(αH0) with
base measure H0 and spread α. Here, We adopt the stick-breaking representation to
express the Dirichlet process and rewrite (3.1) as:





νq ∼ H0(ν), q = 1, 2, ...,
π1 = v1, πq = (1− v1)(1− v2)....(1− vq−1)vq, q ≥ 2
vq ∼ Beta(1, α)
where {di}s are allocation parameters used to identify the νdi associated with νq and
locate the measurements ηi to the parameter value νdi .
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Gibbs sampler
Gibbs sampling methods for Dirichlet process of mixture based on the hierarchical
structure were being developed recently. Ishwaran and James (2001) proposed a
blocked Gibbs sampler with resorting to a finite dimensional Dirichlete priors. Walk-
er (2007) presented a slice sampling method and Papaspiliopoulos and Roberts (2008)
developed a retrospective sampling method. Both of them provided an approach to
the posterior simulation without approximation. Papaspiliopoulos (2008) composed
those two methods and proposed an efficient exact block Gibbs sampler which we
would like to utilize in the following MCMC algorithm. The latent variable ui is con-
structed to make the conditional distribution of the allocation parameter d convenient
to achieve. We only describe the sampling procedure without derivation.
In out our algorithm, H0(·) is specified to be an exponential distribution Exp(1).
The gamma distribution G(aα, bα) is provided as the prior for the concentration pa-
rameter α. The dimension of Dirichlete priors is set at N at the beginning and
update through the iterates of the algorithm. The algorithm of posterior computa-
tion is carried out via the following steps after specifying the initial values for the
hyper parameters.




for zij > 0 if δij = 1
and {zijl}kl=1 ∼M
{
zij, (pij1, pij2, ..., pijl)
}
,
whereM denotes a multinomial distribution and pijl = γjlIl(ci)/
∑k
l=1 γjlIl(ci)
for l = 1, ...k, i = 1, 2, ...n, j = 1, 2.
2. Sample γjl ∼ G
[
1 +∑ni=1 zijl, λj +∑ni=1 Il(ci) exp(x′iβj)ηi],
Sample the λj ∼ G(aλ + k, bλ +
∑k
l=1 γjl).
3. Sample νq ∼ H(·)
∏
di=q G(ηi|νdi , νdi) for q = 1, 2, ...N .
4. Sample vq from Beta(1 +mq, n+ α−
∑q
i=1 mi) , where mq =
∑n
i=1 1(di = q)
Calculate π1 = v1, πq = (1− v1)(1− v2)...vq, for q = 2, ...N .
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5. Sample ui from uniform(0, wdi). Let u∗ = min(u1, ...un).
If ∑Nq=1 πq > 1 − u∗, P (di = q) ∝ G(ηi|νq, νq)1(ui < wdi=q) i = 1, 2, ...n, other-
wise, N = N + 1, vN ∼ Beta(1, α), νN ∼ G(·), πN = vNΠq<N(1− vq).
6. Sample α from G
{

























8. Sample each component of βj by ARMS.
3.4 Simulation
Based on the proposed approaches, simulation studies are conducted to evaluate the
performance. The exact failure time Tj is generated from the true model
Fj(t|x1, x2, η) = 1− exp{−Λ0j(t) exp(β(j)1 x1 + β
(j)
2 x2)η}, j = 1, 2,
where x1 is a Bernoulli(0.5) random variable and x2 is a normal variable with mean 0
variance 0.52, and the regression parameters β(j)1 s take 1 or 0 and β
(j)
2 s take 0 or −1.
The true cumulative baseline function is Λ0j(t) = log(1 + t+ t2) + t3/2. The censored
time C is generated from truncated exponential distribution E(1) with support on
[0, 10], since the true survival probability is too small when failure time is greater than
10. We generate the censoring indicator δj by sampling from a Bernoulli distribution
with probability of success F (C|x1, x2, η) for each j. We consider two scenarios for the
true frailty distribution: one is G(1, 1); the other is mixture log-normal distribution:
f(η) = 0.25LN (−1, 2) + 0.50LN (−1, 0.61) + 0.25LN (0.5, 0.39),
where LN (µ, σ2) denotes the log-normal distribution with location parameter µ and
scale parameter σ. For each parameter configuration, we generated 100 data sets
with each containing 300 observations.
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In the specifying of monotone splines, we chose degree 3 and took 15 equally spaced
knots spanning in the range of observation times. To implement the computation,
We specified aλ = bλ = 1 give a diffuse gamma prior for the hyper-parameter λ.
In the setting of the exact gibbs sampler of DPGM, besides the above specification,
the start value for N is 10 and aα = bα = 1. For each data set, we executed 6000
iterations and burn in the first 1000 ones.
Table 3.1 summarizes the results based on the first scenario in which the true
frailty distribution is G(1, 1). As we can observe, we apply two approaches and both
of them provide good estimation. The biases are small, ESDs are close to SSDs, and
the CP95s are close to the nominal value 0.95. Table 3.2 presents the results under the
second scenario. The small biases, the agreement between ESDs and SSDs, CP95s
close to 0.95 prove that two approaches have good performance. It suggests that
the Gamma frailty PH model is robust to misspecification of the frailty distribution.
Moreover, because Gamma-frailty PH model carries the capability to quantify the
association of the events, we prefer the gamma frailty model to Dirichlet process
mixture gamma model.
3.5 Prevalence of antibodies to hepatitis B and HIV
In this analysis, we apply the proposed methods with the same real data as chapter
2 but consider two risk factors, whether a participant had drug injection before (x1
taking 1 for yes and 0 for no), whether a participant had been treated for STIs before
(x2 taking 1 for yes and 0 for no). The censoring time is taken to be the age at
the survey. There are 1097 prisoners who had complete information for this survey
for this analysis. For the monotone spline specification, we take 3 for the degree
and try different numbers of equally spaced knots within the data range. Table 3.3
presents the estimation results when using different numbers of knots together with
the LPML (Log pseudo marginal likelihood) which is obtained from the summation
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of log conditional predictive ordinates (Gelsser and Eddy, 1979; Gelfand and Dey,
1994). The gamma frailty model gives relatively robust estimation results when using
different number knots. We choose the results using 4 interior knots since it has the
largest PML. Having drug injection history and being treated for STIs both increase
the risk of hepatitis B and HIV. These conclusions are more clear from Figure 3.1
and Figure 3.2, which plot the estimated marginal cumulative incidences (1−S(t|x))
of hepatitis B and HIV respectively for different subgroups with x = (0, 0), (1, 0),
(0, 1), and (0, 0). We obtain τ̂ = 0.52 with 90% confidence interval (0.28, 0.68). This
suggests that there is medium to strong correlation between hepatitis B and HIV.
Ignoring this correlation typically will lose efficiency.
Further more, we apply the DPGM to the data with the optimal number of knots
in Gamma-frailty PH model. Table 3.4 provides a close result to Table 3.3. Figure
3.3 and 3.4 show us the good mixing for the regression parameter estimation.
3.6 Discussion
In this chapter, we have developed an easy-to-implement Bayesian approach to ana-
lyze the bivariate current status data. We provide a flexible and convenient framework
based on Gamma frailty model to estimate the regression parameters as well as the
correlation component. The monotone spline approximation of the baseline and the
data augmentation greatly improve the computation efficiency. We adopt a nonpara-
metric approach (DPGM)to relax the frailty distribution assumption. Our MCMC
algorithms work well and have good mixing property. Based on the results in sim-
ulation and real data, the gamma frailty model is robust to the missspecification of
true frailty distribution. The ability of summarizing the correlation encourages us to
fit the proposed model in the application study.
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Figure 3.1 The estimated marginal cumulative incidence functions of hepatitis B
for different subgroups. Here x = (x1, x2), where x1 denotes whether a person had
drug infection history, x2 denotes whether a person had been treated for STIs
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Figure 3.2 The estimated marginal cumulative incidence functions of HIV for
different subgroups. Here x = (x1, x2), where x1 denotes whether a person had drug
infection history, x2 denotes whether a person had been treated for STIs.
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Figure 3.3 The traceplots of the iteration number against the values of the draw of
the regression parameters at each iteration based on Gamma-frailty PH model with
4 equal spaced knots.
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Figure 3.4 The traceplots of the iteration number against the values of the draw of
the regression parameters at each iteration based on DPGM with 4 equal spaced
knots.
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Table 3.1 Simulation results for the regression parameters and the variance
parameter of the gamma frailty when the true frailty distribution is G(1, 1). BIAS
denotes the average of the point estimates minus the true value, ESD is the average
of estimated standard deviations, SSD is the sample standard deviation of the point
estimates, and CP95 is the 95% coverage probability.





2 Est Bias SSD ESD CP95 Est Bias SSD ESD CP95
1 0 β̂1
(1) -0.0389 0.4265 0.3631 0.92 β̂1
(1) -0.0036 0.3724 0.3707 0.97
β̂2
(1) -0.0530 0.3748 0.3572 0.92 β̂2
(1) -0.0279 0.4027 0.3636 0.96
β̂1
(2) -0.0374 0.4146 0.3647 0.92 β̂1
(2) 0.0341 0.4192 0.3712 0.89
β̂2
(2) -0.0273 0.3866 0.3568 0.94 β̂2
(2) 0.0144 0.3635 0.3634 0.95
ν̂ 0.0986 0.3516 0.3314 0.9 - - - - -
1 -1 β̂1
(1) -0.0493 0.3524 0.3606 0.93 β̂1
(1) -0.0351 0.3745 0.3819 0.94
β̂2
(1) -0.014 0.3928 0.3765 0.93 β̂2
(1) -0.0899 0.4299 0.4006 0.94
β̂1
(2) -0.0312 0.3633 0.3691 0.93 β̂1
(2) -0.0026 0.3294 0.3855 0.99
β̂2
(2) -0.0383 0.4150 0.3786 0.91 β̂2
(2) -0.0778 0.4013 0.3974 0.94
ν̂ 0.0461 0.3135 0.3055 0.95 - - - - -
0 0 β̂1
(1) -0.0301 0.3333 0.3325 0.94 β̂1
(1) 0.0012 0.3189 0.3374 0.98
β̂2
(1) -0.0123 0.3398 0.3364 0.95 β̂2
(1) 0.0279 0.2752 0.3491 1
β̂1
(2) -0.0522 0.2877 0.3332 0.99 β̂1
(2) -0.0385 0.3382 0.3420 0.94
β̂2
(2) -0.0470 0.3032 0.3355 0.96 β̂2
(2) 0.0034 0.3218 0.3516 0.96
ν̂ 0.0536 0.3422 0.3458 0.96 - - - - -
0 -1 β̂1
(1) -0.0087 0.3107 0.3378 0.95 β̂1
(1) -0.0525 0.3583 0.3448 0.93
β̂2
(1) 0.0276 0.3802 0.3635 0.97 β̂2
(1) -0.0488 0.4060 0.3781 0.91
β̂1
(2) -0.0091 0.3136 0.3366 0.95 β̂1
(2) -0.0871 0.3519 0.3425 0.94
β̂2
(2) 0.0338 0.3325 0.3603 0.97 β̂2
(2) -0.0397 0.3880 0.3768 0.93
ν̂ 0.0630 0.3919 0.3406 0.91 - - - - -
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Table 3.2 Simulation results for the regression parameters and the variance
parameter of the gamma frailty when the true frailty distribution mixture of
log-Normal distributions with three components. BIAS denotes the average of the
point estimates minus the true value, ESD is the average of estimated standard
errors, SSD is the sample standard deviation of the point estimates, and CP95 is
the 95% empirical coverage probability.
Gamma frailty model DPGM
β1 β2 Est Bias SSD ESD CP95 Est Bias SSD ESD CP95
1 0 β̂1
(1) -0.0054 0.2787 0.2771 0.96 β̂1
(1) -0.0146 0.2655 0.2799 0.96
β̂2
(1) 0.0095 0.2530 0.2705 0.96 β̂2
(1) 0.0086 0.2564 0.2700 0.95
β̂1
(2) -0.0244 0.2893 0.2779 0.95 β̂1
(2) -0.0347 0.2796 0.2787 0.93
β̂2
(2) 0.0161 0.2609 0.2723 0.97 β̂2
(2) 0.0104 0.2595 0.2715 0.97
1 -1 β̂1
(1) -0.0337 0.2722 0.2813 0.96 β̂1
(1) 0.0101 0.2875 0.2865 0.94
β̂2
(1) -0.0277 0.2581 0.2904 0.97 β̂2
(1) -0.0140 0.2987 0.2938 0.95
β̂1
(2) -0.0599 0.2878 0.2836 0.94 β̂1
(2) -0.0289 0.2702 0.2858 0.97
β̂2
(2) -0.0347 0.2739 0.2900 0.94 β̂2
(2) 0.0059 0.2911 0.2936 0.96
0 0 β̂1
(1) -0.0022 0.2829 0.2674 0.95 β̂1
(1) -0.0273 0.2686 0.2637 0.95
β̂2
(1) -0.0075 0.2839 0.2667 0.91 β̂2
(1) -0.0466 0.2177 0.2233 0.94
β̂1
(2) 0.0353 0.2583 0.2629 0.95 β̂1
(2) -0.0327 0.2418 0.2678 0.99
β̂2
(2) 0.0317 0.2831 0.2692 0.9 β̂2
(2) -0.0125 0.2680 0.2663 0.95
0 -1 β̂1
(1) -0.0182 0.2670 0.2606 0.92 β̂1
(1) 0.0055 0.2496 0.2615 0.97
β̂2
(1) -0.0013 0.2899 0.2857 0.94 β̂2
(1) 0.0160 0.2856 0.2902 0.96
β̂1
(2) -0.0419 0.2795 0.2659 0.93 β̂1
(2) -0.0107 0.2613 0.2652 0.96
β̂1
(2) -0.0302 0.3422 0.2875 0.94 β̂2
(2) -0.0028 0.3292 0.2892 0.93
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Table 3.3 Point estimates and 90% confidence interval of the covariate effects on
hepatitis and HIV based on Gamma frailty model when using different numbers of
knots. The two covariates in order are whether having drug injection, whether being
treated for sexually transmitted infections. Column 6 shows the estimation of
gamma variance parameter ν, column 7 is the estimation of Kendall’s τ and its 90%
confidence interval, and columns 8 provides the LPML (Log pseudo marginal








2 ν̂ τ̂ LPML
3 0.62 3.04 0.87 1.08 0.72 0.45 -357.86
(0.02,1.27) (2.30,3.99) (-0.08,1.76) (0.23,1.96) (0.24,1.51) (0.22,0.71)
4 0.66 3.33 0.86 1.02 0.53 0.52 −355.63
(0.03,1.33) (2.55,4.10) (-0.08,1.75) (0.17,1.90) (0.24,1.29) (0.24,0.70)
5 0.60 3.03 0.80 0.98 0.77 0.45 -357.42
(-0.03,1.24) (2.31,3.85) (-0.13,1.70) (0.13,1.85) (0.28,1.98) (0.15,0.67)
7 0.62 3.09 0.75 0.86 0.55 0.51 -356.08
(0.01,1.28) (2.32,3.87) (-0.19,1.66) (0.03,1.68) (0.22,1.17) (0.25,0.71)
10 0.60 2.97 0.69 0.69 0.52 0.53 -358.43
(0.08,1.13) (2.33,3.68) (-0.12,1.42) (0.02,1.37) (0.22,1.10) (0.31,0.69)
12 0.58 2.86 0.65 0.61 0.48 0.55 -362.35
(0.04,1.16) (2.22,3.57) (-0.12,1.34) (-0.05,1.29) (0.20,1.07) (0.32,0.71)
15 0.57 2.74 0.57 0.45 0.40 0.58 -362.97
(-0.10,1.27) (2.08,3.47) (-0.36,1.45) (-0.37,1.22) (0.16,0.81) (0.34,0.77)
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Table 3.4 Point estimates and 90% confidence interval of the covariate effects on
hepatitis and HIV based on DPGM when using different numbers of knots. The two










3 0.60 2.98 0.88 1.08
(0.12,1.10) (2.36,3.68) (0.10,1.62) (0.38,1.80)
4 0.63 3.32 0.85 1.02
(0.13,1.17) (2.6,4.08) (0.06,1.58) (0.33,1.75)
5 0.60 3.10 0.82 1.01
(0.08,1.13) (2.5,3.77) (0.05,1.55) (0.26,1.78)
7 0.61 3.10 0.75 0.88
(0.07,1.15) (2.44,3.77) (-0.05,1.49) (0.21,1.58)
10 0.59 2.90 0.67 0.71
(0.06,1.11) (2.30,3.50) (-0.12,1.44) (0.02,1.42)
12 0.57 2.85 0.63 0.64
(0.03,1.12) (2.25,3.54) (-0.13,1.38) (-0.04,1.3)
15 0.56 2.72 0.55 0.49
( 0,1.12) (2.12,3.35) (-0.23,1.31) (-0.15,1.14)
53
Chapter 4
Frailty PH models for bivariate general
interval-censored data allowing weak
dependence and independence
4.1 Introduction
When investigating chronic diseases, researchers often adopt periodic clinical exami-
nations or laboratory tests on each patient to monitor the time to onset (or relapse) of
the disease. Interval-censored data are generated if the exact failure time is not avail-
able to observe but known within some interval due to an observation of the changed
status in the study. Repeated in the introduction chapter, interval censored data
involve three censoring types: right-censoring, left-censoring and interval-censoring.
Current status data or Case I interval-censored data is an important special case
of interval-censored data which contains either left- or right-censored observation-
s (Groeneboom and Wellner 1992). Case II interval-censored or general interval
censored-data contain observations with all these censoring types and hence are more
complicated.
An example of interval-censored data was described in Finkelstein and Wolfe
(1985) on breast cancer patients. Multivariate interval censored data often arise when
subjects experience multiple correlated events. For example, Goggins and Finkelstein
(2000) gave details of the ACTG 181 study, which was designed to investigate the
opportunistic infection cytomegalovirus referred to as shedding of HIV in the blood
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and urine samples of patients.
In literature, types of methods were contributed to analyze the interval-censored
data. Without considering covariates, Turnbull (1976) proposed an NPMLE estima-
tor (Turnbull’s estimator) of the survival function for interval-censored data. Gen-
tleman and Geyer (1994) proved a necessary and sufficient condition (Kuhn-Tucker
conditions) for a self-consistent estimator to be the NPMLE. Some other papers re-
lated to nonparametric analysis of interval-censored data include Andersen and Ronn
(1995); Yu et al. (2000). In other regression analysis of interval-censored data, the
primary interests are to estimate covariate effects and the baseline survival or hazard
function. Available approaches for the regression analysis of interval-censored data
include Finkelstein (1986), Huang and Rossini (1997), Betensky et al. (2002), Lin
and Wang (2009)and McMahan et al. (2013) among many others.
For multivariate interval-censored data, it is of interest to quantify the correlation
among those failure events in addition to estimating the survival functions and co-
variate effects. Typically, the analysis of correlated survival data is approached from
either one of two perspective; i.e., from either the marginal likelihood or frailty model
approach. In the introduction part, we present a brief review of the current methods
for multivariate interval-censored data.
In this chapter, we first propose a Bayesian approach to analyze the multivariate
interval-censored data under Gamma-frailty PH model. Monotone spline approxi-
mation to cumulative baseline hazard functions is adopted. An efficient Bayesian
MCMC with data augmentation is developed to implement the model. Notice from
the simulation study that if the two interested events are independent, the proposed
method provides a large bias in the estimation of regression coefficients. We ex-
tend the Gamma-fraily PH model to a PH model with a mixture distributed frailty
allowing to handle both independent and dependent cases. The remainder of this
chapter organizes as follows: in section 4.2, we introduce Gamma frailty PH model
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along with a Bayesian framework to implement it; In section 4.3, Gamma mixture
frailty is present with an adjusted MCMC algorithm. An extensive simulation study
is conducted to evaluate and compare the performance with two PH frailty models
in section 4.4. In section 4.5, an application study is used to illustrate two methods.
4.2 Gamma frailty PH model
Data Structure, Likelihood
Suppose two interested failure times on n subjects awaiting for investigation. Let
Tij be the exact failure time for the jth event on the ith subject which is denoted
by a (p × 1) vector xi. Assuming we have a sequence of Ji independent observation
times (c1, c2, ...cJi) on each subject for both events where Ji is set to be any random
number to avoid making the unrealistic assumption of requiring the same number
of observational times for all subjects in the study. Owing to the interval-censored
data structure, Tij is not available to observe exactly but rather lies in some interval
generated by some observation times: Tij ∈ (Lij, Rij), where Lij and Rij are chosen
from {0, c1, c2, ...cJi ,∞}. Three censoring types can appear in interval-censored data:
right censoring, left censoring and interval censoring. We use three indicators δij1 δij2
and δij3 to identify the corresponding censoring type for Tij and they are subject to
δij1 + δij2 + δij3 = 1.
By multiplying the shared frailty η, the univariate Proportional Hazards model
is extended to bivariate PH frailty model defining the hazard function given xi and
ηi as
λij(t,x, η) = λ0j(t) exp(x′iβj)ηi,
where λ0j(t) is the conditional cumulative baseline hazard for the jth event and βj is
the corresponding vector of regression parameters. This model suggests that the two
interested failure times are conditional independent given η. Let Fij(·|xi, ηi) be the
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conditional cumulative distribution function for the jth event, thus, under the PH
frailty model,
Fij(t|x, η) = 1− exp(−Λ0j(t) exp(x′iβj)ηi). (4.1)
To derive the observed data likelihood, we use several common assumptions as
in Chen et.al.(2009), Hens et al.(2009) that is the two failure time are subject to
the univariate censoring among the observation times and non-informative censoring
scheme is adopted for which the failure time is independent of censoring time given the
covariates. Consequently, the observations consisting of n subjects can be represented
succinctly as {(Lij, Rij,xi, δij1, δij2, δij3), i = 1, ..., n, j = 1, 2}. Under the specify








F (Rij|xi, ηi)− F (Lij|xi, ηi)
}δij2{1− F (Lij|xi, ηi)}δij3]π(ηi|ν)dηi,
(4.2)
where Lij and Rij are the left- and right- ending point of the censoring interval and
π(ηi|ν) is the density distribution of ηi associated with parameter ν. If η follows
Gamma distribution G(ν, ν), (4.1) is specified as Gamma frailty PH model.
Monotone splines to approximate Λ0j(t)
To conquer the challenge to approximate the proper cumulative baseline hazard func-
tion Λ0j(t) without losing the flexibility or computational burden, we still apply the
monotone splines approximation (2.4) encouraged by the succeed in the previous
chapters. Generally, we intend to use the monotone splines with degree 3 and equally
placed knots in the range of the censoring times.
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Data Augmentation
To implement a Bayesian sampling method, we are required to derive the posterior
distribution for the unknown parameters, particularly, θ = (β1,β2,γ1,γ2, ν) when
applying the spline representation. However, the complicated form of observed like-
lihood (4.2) makes it impossible to obtain the standard posterior distribution when
plus a prior. In such a situation, Metropolis-Hastings steps are proposed to sample
any nonstandard probability distribution with a chance of poor mixing of Markov
chains happening and a great effort in computation.
Followed the novel augmenting scheme developed in Lin et al.(2013), we connect
the Gamma PH frailty model and the nonhomogeneous Poisson process {Nj(t) : t ≥
0} with intensity function λ0j(t) exp(x′βj)η, where η follows the Gamma distribution.
Assume Tj as the first arrival epoch in the process,
P (Tj > t) = P{Nj(t) = 0} = exp{−Λ0j(t) exp (x′βj)η},
from which, this is the survival function for Tj under the Gamma frailty PH model.
Further more, for any two time points t1 < t2 , if t1 > Tj, then Nj(t) > 0; if
t1 < Tj < t2, then Nj(t1) = 0 and Nj(t2) > 0 and if t2 < Tj, then Nj(t2) = 0.
Therefore, by the property of the Poisson process we have
P (Tj < t1|η) = 1− exp{−Λ0j(t1) exp (x′βj)η};
P (t1 < Tj < t2|η) = P{Nj(t1) = 0&Nj(t2) > 0}
= P{Nj(t1) = 0} − P{Nj(t2) = 0}
= exp{−Λ0j(t1) exp (x′βj)η} − exp{−Λ0j(t2) exp (x′βj)η}.
P (Tj > t2|η) = exp{−Λ0j(t2) exp (x′βj)η}
Moreover, we can produce zj and wj whereas zj ∼ P{Λ0j(t1) exp (x′βj)η} and wj ∼
P [{Λ0j(t2)− Λ0j(t1)} exp (x′βj)η] to present the relationship between the PH model
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and Poisson process. That is, we have
P (Tj < t1) = P (zj > 0);
P (t1 < Tj < t2) = P (zj = 0 & wj > 0)
P (Tj > t2) = P (zj = 0 & wj = 0).
To start the first augmentation step, we let tij1 = Rij1(δij1=1) + Lij1(δij1=0) and
tij2 = Rij1(δij2=1) + Lij1(δij3=1). We introduce latent Poisson variables as zij ∼
P{Λ0(tij1) exp(x′iβj)ηi} and wij ∼ P [{Λ0(tij2) − Λ0(tij1)} exp(x′iβj)ηi]. Apparent-
ly, We have only one constraint zij > 0 in the case of left-censoring and in the case of
interval-censoring, there are constraints zi = 0 and wi > 0. For right-censoring, there
are constraints zi = 0 and wi = 0. As a result, the augmented likelihood function





j=1P(zij)P(wij)δij2+δij3{δij11(zij>0) + δij21(zij=0,wij>0) + δij31(zij=0,wij=0)}
π(ηi).
It is apparent that integrating out zijs, wijs, and ηis will result in (4.2).
Further more, applying the spline formulation, we could decompose zij, wij into
independent Poisson variables zijls and wijls by defining zij =
∑k
l=1 zijl and wij =∑k
l=1 wijl, where
zijl ∼ P{γjlIl(tij1) exp(x′iβj)}ηi; wijl ∼ P [γjl{Il(tij2)− Il(tij1)} exp(x′iβj)ηi].
Hence, under the specification above, we arrive at the conditional likelihood function











which is subject to the constraints ∑l zijl > 0 if δij1 = 1, ∑l zijl = 0 and ∑l wijl > 0
if δij2 = 1, and
∑
l zijl = 0 and
∑
l wijl = 0 if δij3 = 1. MCMC assisted posterior
inferences will be provided in the next section.
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MCMC algorithm
We assign independent exponential priors Exp(λj) for the coefficients γjls of monotone
spline, and adopt a gamma distribution G(aλ, bλ) as a hyper prior for each λj. The use
of shrinkage priors for the spline coefficients is to address the over-fitting problems
when a large quantity of knots are placed. For regression parameters βjs we apply
an independent normal distribution N(µj, δ2j ) by which is log-concave. The adaptive
rejection Metropolis sampling (ARMS) (Gilks and Wild, 1992) is used when direct
sampling is not feasible. After assigning the initial values for hyper parameters, our
MCMC algorithm iterates with the following steps:
1. Sample zijs, zijls, wijs, and wijls. Let zij = 0 and wij = 0 for all i and j, and
zijl = 0 and wijl = 0 for all l. If δij1 = 1, then sample
zij ∼ P{Λ0j(Ri) exp(x′iβj)ηi}1(zij>0),
(zij1, · · · , zijk) ∼ M(zij,pij), pij ∝ {γj1I1(Ri), . . . , γjkIk(Ri)},
whereM denotes a multinomial distribution. If δji2 = 1, then sample
wij ∼ P [{Λ0(Ri)− Λ0(Li)} exp(x′iβj)ηi]1(wij>0),
(wij1, · · · , wijk) ∼ M(wij, qij),
where
qij ∝ [γj1{I1(Ri)− I1(Li)}, . . . , γjk{Ik(Ri)− Ik(Li)}]
.
2. Sample γjl from Gamma distribution G(aγjl , bγjl), where




bγjl = λj +
∑
i
exp(x′iβj)ηi{(δij1 + δij2)Il(Ri) + δij3Il(Li)}.




4. Sample ηi from a Gamma distribution G(aηi , bηi), where




bηi = ν +
∑
j
{Λ0j(Ri) exp(x′iβj)(δij1 + δij2) + δij3Λ0j(Li) exp(x′iβj)}.










− exp (x′iβj)ηi{Λ0j(Ri)(δij1 + δij2) + Λ0j(Li)δij3}
]
f(βjl)
respectively, where f(βjl) is a normal prior distribution.
One may notice that our algorithm mostly contains direct sampling steps from stan-
dard posterior distributions except for regression parameters and Gamma variance
parameter which can be updated quickly by ARMS. The MCMC algorithm is imple-
ment using R and the code is available upon request.
4.3 Mixture frailty PH model
To be more general, in the phenomenon that the two failure times are barely correlated
or almost completely independently, the Gamma distribution is not appropriate to
be chosen as the frailty distribution. Motivated by the simulation performance in the
following section, we extended the Gamma-frailty PH model to the Gamma mixture
frailty model a compromising to address the problem arisen by that the random effects
have zero variance. We assume the following frailty density:
η ∼ πδ1(·) + (1− π)G(·; ν, ν).
The case η = 1 means there is no heterogeneity among the two events. The mixture-
frailty PH model retains the good properties. The marginal and joint survival function
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can be obtained in a closed form as






1 + ν−1Λ0j(t) exp(x′βj)
}−ν
;
S(t1, t2|x) = π exp
{
−∑2j=1 Λ0j(t) exp(x′βj)}+ (1− π){1 +∑2j=1 ν−1Λ0j(t) exp(x′βj)}−ν .
Even with the slight change of the frailty distribution, the Kendall’s τ is available to
quantify the correlation structure via τ = 1− π1 + 2ν after the estimation of ν and π.
The MCMC algorithm is developed based on the one under Gamma frailty PH
model. The sampling steps are all exact same except for sampling η. We adjust the
step and add one more step to sample π.
1. sample ηi from a mixture distribution




1 + (1− π)ν
ν Γ(ãηi)









b̃ηi = ν +
∑
j
{Λ0j(Ri) exp(x′iβj)(δij1 + δij2) + δij3Λ0j(Li) exp(x′iβj)}.
2. Sample an additional parameter π from
π ∼ Beta(1 +
∑
i
1(ηi = 1), n+ 1−
∑
i
1(ηi 6= 1)). (4.4)
4.4 Simulation
We conduct a simulation study to evaluate the proposed approaches for two PH
frailty models. We generate the paired failure times from F (tj|x1, x2, η) = 1 −
exp{−Λ0j(t) exp(βj1x1 + βj2x2)η}, where x1 is a Bernoulli(0.5) random variable and
x2 is a N(0, 0.52) random variable. The true cumulative hazard is defined as Λ0j(t) =
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log(1 + t+ t2) + t3/2 and the true value for βj1 is 1 or 0 and βj2 is −1, 0, or 1. Based
on the assumption of univariate censoring that is the two events share the same ran-
dom observation, we define the number of randomness as equal to 1 plus a Poisson
random variable with mean 2. We generate the gaps between the adjacent observa-
tions through independent exponential distributions with mean 1 and the observation
times are produced by cumulating the gaps. Accordingly the censoring indicator can
be inferred by comparing the observations with the exact failure time.
To examine the performance of the MCMC algorithm on the two proposed PH
frailty models, we consider two scenarios for frailty generation based on two distri-
butions. One is Gamma distribution G(1, 1) and the other is ηis are all 1. Hence, we
obtain the dependent bivariate failure times and independent ones respectively.
For the monotone spline specifications, we choose degree 3 for adequate smooth-
ness and select 15 equally spaced knots. We specify the normal priors N(0, 102) for
βs and take aλ = bλ = 1 for hyper parameters γjls. We generate 100 data sets with
each containing 300 observations for each scenario. For each data set, we execute
6000 iterations and burn in the first 1000 ones. Fast convergence and good mixing
property are observed in all the simulations.
Table 4.1 shows the behaviour under dependence in which the frailty is generated
from gamma distribution. Table 4.2 exhibits the results of estimation of βjs and
the correlation measurement Kendall’s τ under the independence case. Bias denotes
the average of the 100 point estimates minus the true value, ESE is presenting the
average of the estimated standard errors, SSD is the sample standard deviation of
the 100 point estimates, and CP95 expresses 95% coverage probability.
From Table 4.1, one can observe the two models performed equivalently well in
the dependent situation. From Table 4.2 We notice that the mixture frailty model
outperform the gamma frailty model with smaller bias and smaller variance.
To formally test the dependence, Bayes factor is calculated during the simulation
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for each set up. Consider the hypothesis test with H0: failure times are dependent
and H1: failure times are independent, the Bayes factor B10 is obtained by calculating









In the independence simulation scenario, the average Bayes factor value of 100 data
sets is approximately 7.86 which sufficiently supports the independence.
Summarily, from two tables, it is concluded that the Bayesian approach for mix-
ture frailty PH model works very well in all three conditions since the Biases are all
close to zeros, ESEs are close to the corresponding SSDs and the CP95s are close to
0.95. The Gamma frailty PH model has a good performance for the correlated failure
times.
4.5 AIDS example
We apply the proposed methods to the bivariate interval-censored data ACTG 181
which arose from the AIDS Clinical Trials Group protocol. The study was carried by
following the patients with observing the instant status of test for CMV shedding in
their blood and urine samples. As discussed in the introduction chapter before, the
exact occurrence time can not be obtained and only known to fall in some observation
interval. From the data set, we found that for time to blood shedding 15 patients
were left censored, 15 were interval censored and 174 were right censored; for the
urine shedding 69 were left censored, 47 were interval censored and 88 were right
censored. The covariate is a binary vector to indicate the CD4 counts. The purpose
of the study is to investigate the effect of CD4 on CMV shedding in blood and urine.
Moreover, we wanted to explore the correlation between the blood shedding and urine
shedding.
We implemented the data with the approaches developed above. Table 4.3 presents
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the results by fitting with the gamma frailty model and with the mixture frailty model.
We found that for both models, the factor effects for blood and urine are all significant
and positive. To describe the degree of correlation, the estimation of Kendall’s τ were
provided and it is 0.5275 for gamma frailty model and 0.4615 for mixture model. We
may conclude that the blood shedding and urine shedding are strongly correlated.
Bayes factor is around 0.37 which provides no evidence against the dependence.
To make a model selection, we formally compared them from Bayesian perspective
by adopting the log scale of pseudo marginal likelihood (LPML) given by the sum of
log of CPO(conditional predictive ordinates), where CPO is defined as
CPOi =
E{ 1
P (Ti1 ∈ ∆i1, Ti2 ∈ ∆i2|β,xi, δi1, δi2)
}
−1, (4.5)
where the ∆i1 and ∆i2 are two intervals containing the failure time ti, and the expec-
tation is taken with respect to the full posterior distribution of β given the observa-
tion data. It can be evaluated by taking the inverse of average {P (Ti1 ∈ ∆i1, Ti2 ∈
∆i2|β,xi, δi1, δi2)}−1 simultaneously with estimating the parameters in Gibbs sam-
pler. The criterion of selecting model is to choose the larger log scale of PML as
ln(PML) = ∑i ln(CPOi). For gamma frailty model ln(PML) is -389.59 which is
smaller than -388.63 for mixture frailty model. Based on the rule, mixture frailty
model is preferable to gamma frailty. Figure 4.1 displayed the discrete values of
ln CPOmixture
CPOgamma
for each subject. There are about 56% of ratios are positive which
support the mixture frailty model.
4.6 Conclusion
In this paper, we have developed a Bayesian method to analyze bivariate interval
censored data under PH frailty model. Our method allows to estimate the regression
parameters and baseline survival function coincidently. To explore the correlation be-
tween two failure times, we made assumptions about the frailty distribution: Gamma
65
distributed or Mixture distribution with point mass at 1. Our approach is able to
estimate the correlation by evaluating the Kendall’s τ under both frailty models. By
examining the distribution form and simulation results, one can learn that the mix-
ture frailty PH model performs better than gamma frailty PH model when the two
follow-up events are independent. We applied the method to the shedding time data
from AIDS study and presented the comparison of models by calculating the PML
which supported the preference of mixture frailty model as well.

























Figure 4.1 The discrete point ratio of CPO in log scale between the two frailty PH
models
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Table 4.1 Simulation results for the regression parameters and the variance
parameter when the true frailty distribution is G(1, 1). BIAS denotes the average of
the point estimates minus the true value, ESD is the average of estimated standard
errors, SSD is the sample standard deviation of the point estimates, and CP95 is
the 95% empirical coverage probability.
Gamma frailty PH model Mixture frailty PH model
β1 β2 Est Bias SSD ESE CP95 Est Bias SSD ESE CP95
1 1 β̂1
(1) -0.0476 0.2643 0.2624 0.90 β̂1
(1) -0.0803 0.2575 0.2559 0.94
β̂2
(1) -0.0989 0.2506 0.2597 0.93 β̂2
(1) -0.1283 0.2439 0.2550 0.93
β̂1
(2) -0.0324 0.2799 0.2616 0.90 β̂1
(2) -0.0642 0.2676 0.2537 0.92
β̂2
(2) -0.0066 0.2706 0.2561 0.94 β̂2
(2) -0.0359 0.2704 0.2550 0.95
ν̂ 0.0388 0.1682 0.1833 0.96 ν̂ -0.0474 0.1489 0.1869 0.93
1 0 β̂1
(1) 0.0116 0.2636 0.2631 0.93 β̂1
(1) -0.0237 0.2543 0.2595 0.93
β̂2
(1) -0.0238 0.2629 0.2618 0.99 β̂2
(1) -0.0162 0.2567 0.2493 0.96
β̂1
(2) -0.0389 0.2128 0.2606 0.98 β̂1
(2) -0.0495 0.2319 0.2554 0.95
β̂2
(2) 0.0131 0.2529 0.2602 0.93 β̂2
(2) 0.0176 0.2430 0.2488 0.94
ν̂ 0.0345 0.1729 0.1841 0.94 ν̂ -0.0466 0.1666 0.1876 0.91
1 -1 β̂1
(1) -0.0586 0.2649 0.2639 0.94 β̂1
(1) -0.0774 0.2680 0.2574 0.90
β̂2
(1) -0.0138 0.2645 0.2642 0.96 β̂2
(1) 0.0067 0.2579 0.2598 0.94
β̂1
(2) -0.0399 0.2304 0.2602 0.98 β̂1
(2) -0.0664 0.2237 0.2578 0.98
β̂2
(2) 0.0159 0.2198 0.2667 0.96 β̂2
(2) 0.0455 0.2114 0.2610 0.97
ν̂ 0.0693 0.1772 0.1912 0.97 ν̂ -0.0408 0.1691 0.1922 0.96
0 1 β̂1
(1) -0.0476 0.2643 0.2624 0.90 β̂1
(1) -0.0472 0.2241 0.2310 0.96
β̂2
(1) -0.0989 0.2506 0.2597 0.93 β̂2
(1) -0.0575 0.2972 0.2439 0.90
β̂1
(2) -0.0324 0.2799 0.2616 0.90 β̂1
(2) -0.0390 0.2298 0.2273 0.93
β̂2
(2) -0.0066 0.2706 0.2561 0.94 β̂2
(2) -0.0481 0.2718 0.2439 0.87
ν̂ 0.0388 0.1681 0.1833 0.96 ν̂ -0.0785 0.1455 0.1909 0.95
0 0 β̂1
(1) -0.0576 0.2264 0.2405 0.95 β̂1
(1) -0.0650 0.2261 0.2344 0.95
β̂2
(1) -0.0130 0.2441 0.2731 0.98 β̂2
(1) -0.0137 0.2442 0.2675 0.98
β̂1
(2) -0.0466 0.2488 0.2420 0.95 β̂1
(2) -0.0517 0.2349 0.2350 0.96
β̂2
(2) -0.0292 0.2375 0.2742 0.98 β̂2
(2) -0.0297 0.2375 0.2665 0.97
ν̂ 0.0157 0.1544 0.1794 0.97 ν̂ -0.0832 0.1339 0.1844 0.96
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Table 4.2 Simulation results for the regression parameters and the association
measurement when the failure events are independent. BIAS denotes the average of
the point estimates minus the true value, ESD is the average of estimated standard
deviations, SSD is the sample standard deviation of the point estimates, and CP95
is the 95% empirical coverage probability.
Gamma frailty PH model Mixture frailty PH model
β1 β2 Est Bias SSD ESE CP95 Est Bias SSD ESE CP95
1 1 β̂1
(1) 0.1527 0.2354 0.2449 0.91 β̂1
(1) 0.0632 0.2397 0.2236 0.93
β̂2
(1) 0.1378 0.2436 0.2474 0.92 β̂2
(1) 0.0531 0.2371 0.2282 0.94
β̂1
(2) 0.1170 0.2404 0.2312 0.93 β̂1
(2) 0.0325 0.2285 0.2229 0.94
β̂2
(2) 0.1248 0.2721 0.2424 0.88 β̂2
(2) 0.0401 0.2657 0.2288 0.91
τ̂ 0.0989 0.0111 0.0201 - τ̂ 0.0234 0.0201 0.0143 -
1 0 β̂1
(1) 0.1812 0.2208 0.2401 0.90 β̂1
(1) 0.0762 0.2250 0.2223 0.95
β̂2
(1) -0.0109 0.2085 0.2186 0.96 β̂2
(1) -0.0093 0.1890 0.1935 0.96
β̂1
(2) 0.1411 0.2193 0.2411 0.93 β̂1
(2) 0.0373 0.2069 0.2240 0.96
β̂2
(2) -0.0334 0.2243 0.2177 0.95 β̂2
(2) -0.0250 0.1947 0.1965 0.96
τ̂ 0.1019 0.01169 0.0264 - τ̂ 0.0237 0.0216 0.0130 -
1 -1 β̂1
(1) 0.1688 0.2222 0.2398 0.96 s β̂1
(1) 0.0677 0.2175 0.2255 0.94
β̂2
(1) -0.1548 0.1950 0.2293 0.92s β̂2
(1) -0.0699 0.1846 0.2157 0.99
β̂1
(2) 0.1180 0.2313 0.2347 0.91 β̂1
(2) 0.0302 0.2219 0.2221 0.96
β̂2
(2) -0.1418 0.2137 0.2274 0.94 β̂2
(2) -0.0576 0.2153 0.2143 0.96
τ̂ 0.1002 0.0117 0.0256 - τ̂ 0.0253 0.0167 0.0215 -
0 1 β̂1
(1) 0.0294 0.1633 0.1935 0.97 β̂1
(1) 0.0222 0.1466 0.1737 0.97
β̂2
(1) 0.1210 0.2152 0.2067 0.91 β̂2
(1) 0.0318 0.2011 0.1943 0.92
β̂1
(2) -0.0120 0.2058 0.1939 0.93 β̂1
(2) -0.0146 0.1898 0.1737 0.91
β̂2
(2) 0.1074 0.1862 0.2073 0.91 β̂2
(2) 0.0151 0.1692 0.1917 0.96
τ̂ 0.0954 0.0124 0.0238 - τ̂ 0.0225 0.0160 0.0194 -
0 0 β̂1
(1) -0.0120 0.1806 0.1933 0.97 β̂1
(1) -0.0159 0.1611 0.1730 0.97
β̂2
(1) 0.0121 0.1957 0.1839 0.91 β̂2
(1) 0.0092 0.1785 0.1656 0.92
β̂1
(2) -0.0344 0.2016 0.1929 0.92 β̂1
(2) -0.0332 0.1798 0.1726 0.93
β̂2
(2) 0.1074 0.1862 0.2073 0.91 β̂2
(2) -0.0113 0.1636 0.1640 0.97
τ̂ 0.0979 0.0096 0.0247 - τ̂ 0.0236 0.0135 0.0236 -
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Table 4.3 Point estimates and 95% confidence interval of the covariate(the count
of CD4) effect on the occurrences of CMV shedding in blood and urine and the
association via Kendall’s τ through the two frailty PH models
Gamma frailty Mixture frailty
Parameter Mean SD 95%CI Mean SD 95%CI
βb 0.9575 0.4350 (0.1296, 1.8407) 0.8019 0.4321 (0.0691, 1.6657)
βu 1.4729 0.3814 (0.7808, 2.2664) 1.2250 0.3735 (0.5297, 1.9887)
τ 0.5275 0.0648 (0.3898, 0.6429) 0.4615 0.0709 (0.3228, 0.5935)
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Appendix A
The conditional expectations in Section 2.3





δi1δi2 − δi1S2(ci|xi)− δi2S1(ci|xi) + S(ci, ci|xi)
+ {S(ci, ci|xi)}
(1+ν−1)
















where Bi(ν,θ) = δi1δi2 log(ν) − δi1S2(ci|xi) log(ν + ρi2) − δi2S1(ci|xi) log(ν + ρi1) +
S(ci, ci|xi) log(ν + ρi1 + ρi2) and ρij = Λ0j(ci) exp(x′iβj) for j = 1, 2 and i = 1, . . . , n.
The derivation of E(ηi|D,θ) and E{log(ηi)|D,θ} arises directly from the aug-
mented likelihood (2.5). When deriving E(zij|D,θ), we first use the law of iterative
expectation







The last step uses the fact that the conditional distribution of zij, given ηi and the
observed data, is a truncated Poisson with a support of all positive integers when δij =
1 and is degenerated at 0 when δij = 0. One can complete the conditional expectation
in the above expression based on the augmented likelihood (2.5). The derivation of
E(zijl|D,θ) is straightforward by using the law of iterative expectation and noting
that the conditional distribution of (zij1, . . . , zijk), given zij, is a multinomial.
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